JP2021084865A - Dental curable composition - Google Patents
Dental curable composition Download PDFInfo
- Publication number
- JP2021084865A JP2021084865A JP2019213309A JP2019213309A JP2021084865A JP 2021084865 A JP2021084865 A JP 2021084865A JP 2019213309 A JP2019213309 A JP 2019213309A JP 2019213309 A JP2019213309 A JP 2019213309A JP 2021084865 A JP2021084865 A JP 2021084865A
- Authority
- JP
- Japan
- Prior art keywords
- curable composition
- particle size
- meth
- filler
- dental
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 88
- 239000002245 particle Substances 0.000 claims abstract description 74
- 239000000178 monomer Substances 0.000 claims abstract description 73
- 239000000945 filler Substances 0.000 claims abstract description 72
- 239000011164 primary particle Substances 0.000 claims abstract description 42
- 239000011256 inorganic filler Substances 0.000 claims abstract description 39
- 229910003475 inorganic filler Inorganic materials 0.000 claims abstract description 39
- 239000003505 polymerization initiator Substances 0.000 claims abstract description 16
- 239000000463 material Substances 0.000 claims abstract description 15
- 238000009826 distribution Methods 0.000 claims abstract description 11
- 230000003595 spectral effect Effects 0.000 claims description 26
- 208000002925 dental caries Diseases 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 17
- 229920000642 polymer Polymers 0.000 claims description 15
- 230000000379 polymerizing effect Effects 0.000 claims description 12
- 238000005259 measurement Methods 0.000 claims description 10
- 238000011049 filling Methods 0.000 claims description 9
- 239000005548 dental material Substances 0.000 claims description 2
- 239000000049 pigment Substances 0.000 abstract description 18
- 239000011350 dental composite resin Substances 0.000 abstract description 5
- 235000019646 color tone Nutrition 0.000 description 46
- 239000000047 product Substances 0.000 description 41
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 36
- -1 acrylic compound Chemical class 0.000 description 33
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 29
- 239000000126 substance Substances 0.000 description 21
- 239000000805 composite resin Substances 0.000 description 17
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 16
- 239000002131 composite material Substances 0.000 description 16
- 238000000034 method Methods 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 15
- 210000004268 dentin Anatomy 0.000 description 15
- 239000000377 silicon dioxide Substances 0.000 description 13
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 11
- 239000011521 glass Substances 0.000 description 9
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 230000008439 repair process Effects 0.000 description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 7
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 6
- 125000005442 diisocyanate group Chemical group 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical group [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000001678 irradiating effect Effects 0.000 description 5
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 239000006087 Silane Coupling Agent Substances 0.000 description 4
- 229910052788 barium Inorganic materials 0.000 description 4
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 4
- 238000005452 bending Methods 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 210000003298 dental enamel Anatomy 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 229920006267 polyester film Polymers 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- ZKFOEDSYSPDTEB-UHFFFAOYSA-N 2-prop-2-enoyloxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1OC(=O)C=C ZKFOEDSYSPDTEB-UHFFFAOYSA-N 0.000 description 3
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 239000001294 propane Substances 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000012798 spherical particle Substances 0.000 description 3
- 238000004381 surface treatment Methods 0.000 description 3
- VZXPHDGHQXLXJC-UHFFFAOYSA-N 1,6-diisocyanato-5,6-dimethylheptane Chemical compound O=C=NC(C)(C)C(C)CCCCN=C=O VZXPHDGHQXLXJC-UHFFFAOYSA-N 0.000 description 2
- XFCMNSHQOZQILR-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOC(=O)C(C)=C XFCMNSHQOZQILR-UHFFFAOYSA-N 0.000 description 2
- IDBVMVIVLISACX-UHFFFAOYSA-N 3-(2-prop-2-enoyloxyethyl)naphthalene-1,2,6-tricarboxylic acid Chemical compound OC(=O)c1ccc2c(C(O)=O)c(C(O)=O)c(CCOC(=O)C=C)cc2c1 IDBVMVIVLISACX-UHFFFAOYSA-N 0.000 description 2
- FGWPHDAPRAREAY-UHFFFAOYSA-N 5-amino-2-prop-2-enoyloxybenzoic acid Chemical compound NC1=CC=C(OC(=O)C=C)C(C(O)=O)=C1 FGWPHDAPRAREAY-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 2
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- KORSJDCBLAPZEQ-UHFFFAOYSA-N dicyclohexylmethane-4,4'-diisocyanate Chemical compound C1CC(N=C=O)CCC1CC1CCC(N=C=O)CC1 KORSJDCBLAPZEQ-UHFFFAOYSA-N 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 2
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 150000003377 silicon compounds Chemical class 0.000 description 2
- 238000003980 solgel method Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- XASAPYQVQBKMIN-UHFFFAOYSA-K ytterbium(iii) fluoride Chemical compound F[Yb](F)F XASAPYQVQBKMIN-UHFFFAOYSA-K 0.000 description 2
- XFHQGYBXSCRMNT-JTQLQIEISA-N (2s)-3-phenyl-2-(prop-2-enoylamino)propanoic acid Chemical compound C=CC(=O)N[C@H](C(=O)O)CC1=CC=CC=C1 XFHQGYBXSCRMNT-JTQLQIEISA-N 0.000 description 1
- RTVWMWLQDABAOV-UHFFFAOYSA-N (3-bromo-4-phosphonooxybutyl) prop-2-enoate Chemical compound C(C=C)(=O)OCCC(COP(O)(O)=O)Br RTVWMWLQDABAOV-UHFFFAOYSA-N 0.000 description 1
- DDKMFQGAZVMXQV-UHFFFAOYSA-N (3-chloro-2-hydroxypropyl) 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CCl DDKMFQGAZVMXQV-UHFFFAOYSA-N 0.000 description 1
- RYWGNBFHIFRNEP-UHFFFAOYSA-N (4-benzoylphenyl) 2-methylprop-2-enoate Chemical compound C1=CC(OC(=O)C(=C)C)=CC=C1C(=O)C1=CC=CC=C1 RYWGNBFHIFRNEP-UHFFFAOYSA-N 0.000 description 1
- MXBHZLBILICSRF-UHFFFAOYSA-N (4-methyl-3-oxopent-4-enyl) N-[2,3-dimethyl-7-[(4-methyl-3-oxopent-4-enoxy)carbonylamino]heptan-2-yl]carbamate Chemical compound C(C(=C)C)(=O)CCOC(=O)NC(C(CCCCNC(=O)OCCC(C(=C)C)=O)C)(C)C MXBHZLBILICSRF-UHFFFAOYSA-N 0.000 description 1
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- JWTGRKUQJXIWCV-UHFFFAOYSA-N 1,2,3-trihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(O)C(O)CO JWTGRKUQJXIWCV-UHFFFAOYSA-N 0.000 description 1
- MYWOJODOMFBVCB-UHFFFAOYSA-N 1,2,6-trimethylphenanthrene Chemical compound CC1=CC=C2C3=CC(C)=CC=C3C=CC2=C1C MYWOJODOMFBVCB-UHFFFAOYSA-N 0.000 description 1
- MSAHTMIQULFMRG-UHFFFAOYSA-N 1,2-diphenyl-2-propan-2-yloxyethanone Chemical compound C=1C=CC=CC=1C(OC(C)C)C(=O)C1=CC=CC=C1 MSAHTMIQULFMRG-UHFFFAOYSA-N 0.000 description 1
- VDYWHVQKENANGY-UHFFFAOYSA-N 1,3-Butyleneglycol dimethacrylate Chemical compound CC(=C)C(=O)OC(C)CCOC(=O)C(C)=C VDYWHVQKENANGY-UHFFFAOYSA-N 0.000 description 1
- VNQXSTWCDUXYEZ-UHFFFAOYSA-N 1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione Chemical compound C1CC2(C)C(=O)C(=O)C1C2(C)C VNQXSTWCDUXYEZ-UHFFFAOYSA-N 0.000 description 1
- DLKQHBOKULLWDQ-UHFFFAOYSA-N 1-bromonaphthalene Chemical compound C1=CC=C2C(Br)=CC=CC2=C1 DLKQHBOKULLWDQ-UHFFFAOYSA-N 0.000 description 1
- SDXHBDVTZNMBEW-UHFFFAOYSA-N 1-ethoxy-2-(2-hydroxyethoxy)ethanol Chemical compound CCOC(O)COCCO SDXHBDVTZNMBEW-UHFFFAOYSA-N 0.000 description 1
- WWVBRUMYFUDEJQ-UHFFFAOYSA-N 1-ethoxyethane-1,2-diol Chemical compound CCOC(O)CO WWVBRUMYFUDEJQ-UHFFFAOYSA-N 0.000 description 1
- OGHGZICIFHRKQM-UHFFFAOYSA-N 1-ethoxythioxanthen-9-one Chemical compound S1C2=CC=CC=C2C(=O)C2=C1C=CC=C2OCC OGHGZICIFHRKQM-UHFFFAOYSA-N 0.000 description 1
- CSCSROFYRUZJJH-UHFFFAOYSA-N 1-methoxyethane-1,2-diol Chemical compound COC(O)CO CSCSROFYRUZJJH-UHFFFAOYSA-N 0.000 description 1
- QZKVUSSYPPWURQ-UHFFFAOYSA-N 1-methylthioxanthen-9-one Chemical compound S1C2=CC=CC=C2C(=O)C2=C1C=CC=C2C QZKVUSSYPPWURQ-UHFFFAOYSA-N 0.000 description 1
- NKVCQMYWYHDOOF-UHFFFAOYSA-N 1-phenoxyethane-1,2-diol Chemical compound OCC(O)OC1=CC=CC=C1 NKVCQMYWYHDOOF-UHFFFAOYSA-N 0.000 description 1
- ZXPIONWRHZTWDD-UHFFFAOYSA-N 10-prop-2-enoyloxydecylphosphonic acid Chemical compound OP(O)(=O)CCCCCCCCCCOC(=O)C=C ZXPIONWRHZTWDD-UHFFFAOYSA-N 0.000 description 1
- YHYCMHWTYHPIQS-UHFFFAOYSA-N 2-(2-hydroxyethoxy)-1-methoxyethanol Chemical compound COC(O)COCCO YHYCMHWTYHPIQS-UHFFFAOYSA-N 0.000 description 1
- HLIQLHSBZXDKLV-UHFFFAOYSA-N 2-(2-hydroxyethoxy)-1-phenoxyethanol Chemical compound OCCOCC(O)OC1=CC=CC=C1 HLIQLHSBZXDKLV-UHFFFAOYSA-N 0.000 description 1
- DGPBVJWCIDNDPN-UHFFFAOYSA-N 2-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=CC=C1C=O DGPBVJWCIDNDPN-UHFFFAOYSA-N 0.000 description 1
- QLTZBYGZXPKHLF-UHFFFAOYSA-N 2-Propylsuccinic acid Chemical compound CCCC(C(O)=O)CC(O)=O QLTZBYGZXPKHLF-UHFFFAOYSA-N 0.000 description 1
- WFSMVVDJSNMRAR-UHFFFAOYSA-N 2-[2-(2-ethoxyethoxy)ethoxy]ethanol Chemical compound CCOCCOCCOCCO WFSMVVDJSNMRAR-UHFFFAOYSA-N 0.000 description 1
- ZHCHRKVXJJJZFX-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]-1-phenoxyethanol Chemical compound OCCOCCOCC(O)OC1=CC=CC=C1 ZHCHRKVXJJJZFX-UHFFFAOYSA-N 0.000 description 1
- HWSSEYVMGDIFMH-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOC(=O)C(C)=C HWSSEYVMGDIFMH-UHFFFAOYSA-N 0.000 description 1
- LTHJXDSHSVNJKG-UHFFFAOYSA-N 2-[2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOCCOC(=O)C(C)=C LTHJXDSHSVNJKG-UHFFFAOYSA-N 0.000 description 1
- MKBQTCKRQGDCLC-UHFFFAOYSA-N 2-[hydroxy(3-prop-2-enoyloxypropoxy)phosphoryl]acetic acid Chemical compound C=CC(=O)OCCCOP(=O)(CC(=O)O)O MKBQTCKRQGDCLC-UHFFFAOYSA-N 0.000 description 1
- QEXZMHOUTNSIDN-UHFFFAOYSA-N 2-[hydroxy(4-prop-2-enoyloxybutoxy)phosphoryl]acetic acid Chemical compound C=CC(=O)OCCCCOP(=O)(CC(=O)O)O QEXZMHOUTNSIDN-UHFFFAOYSA-N 0.000 description 1
- QVKZYFAUDMTVKB-UHFFFAOYSA-N 2-[hydroxy(5-prop-2-enoyloxypentoxy)phosphoryl]acetic acid Chemical compound C=CC(=O)OCCCCCOP(=O)(CC(=O)O)O QVKZYFAUDMTVKB-UHFFFAOYSA-N 0.000 description 1
- DVRDWDXWGKCYTR-UHFFFAOYSA-N 2-amino-3-prop-2-enoylbenzoic acid Chemical compound NC1=C(C(O)=O)C=CC=C1C(=O)C=C DVRDWDXWGKCYTR-UHFFFAOYSA-N 0.000 description 1
- ZCDADJXRUCOCJE-UHFFFAOYSA-N 2-chlorothioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC(Cl)=CC=C3SC2=C1 ZCDADJXRUCOCJE-UHFFFAOYSA-N 0.000 description 1
- ASEUXRQULQEGGL-UHFFFAOYSA-N 2-decyl-2-prop-2-enoyloxypropanedioic acid Chemical compound CCCCCCCCCCC(C(O)=O)(C(O)=O)OC(=O)C=C ASEUXRQULQEGGL-UHFFFAOYSA-N 0.000 description 1
- QSRMLPCDUQJASF-UHFFFAOYSA-N 2-dodecyl-2-prop-2-enoyloxypropanedioic acid Chemical compound C(C=C)(=O)OC(CCCCCCCCCCCC)(C(=O)O)C(=O)O QSRMLPCDUQJASF-UHFFFAOYSA-N 0.000 description 1
- KMNCBSZOIQAUFX-UHFFFAOYSA-N 2-ethoxy-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(OCC)C(=O)C1=CC=CC=C1 KMNCBSZOIQAUFX-UHFFFAOYSA-N 0.000 description 1
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 1
- FLFWJIBUZQARMD-UHFFFAOYSA-N 2-mercapto-1,3-benzoxazole Chemical compound C1=CC=C2OC(S)=NC2=C1 FLFWJIBUZQARMD-UHFFFAOYSA-N 0.000 description 1
- BQZJOQXSCSZQPS-UHFFFAOYSA-N 2-methoxy-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(OC)C(=O)C1=CC=CC=C1 BQZJOQXSCSZQPS-UHFFFAOYSA-N 0.000 description 1
- AUZRCMMVHXRSGT-UHFFFAOYSA-N 2-methylpropane-1-sulfonic acid;prop-2-enamide Chemical compound NC(=O)C=C.CC(C)CS(O)(=O)=O AUZRCMMVHXRSGT-UHFFFAOYSA-N 0.000 description 1
- DPEWGZYRIAXJOK-UHFFFAOYSA-N 2-nonyl-2-prop-2-enoyloxypropanedioic acid Chemical compound C(C=C)(=O)OC(CCCCCCCCC)(C(=O)O)C(=O)O DPEWGZYRIAXJOK-UHFFFAOYSA-N 0.000 description 1
- PYYUOCGLIQVVIS-UHFFFAOYSA-N 2-octyl-2-prop-2-enoyloxypropanedioic acid Chemical compound C(C=C)(=O)OC(CCCCCCCC)(C(=O)O)C(=O)O PYYUOCGLIQVVIS-UHFFFAOYSA-N 0.000 description 1
- CBNVXKBMPATGEM-UHFFFAOYSA-N 2-pentyl-2-prop-2-enoyloxypropanedioic acid Chemical compound C(C=C)(=O)OC(CCCCC)(C(=O)O)C(=O)O CBNVXKBMPATGEM-UHFFFAOYSA-N 0.000 description 1
- UDXXYUDJOHIIDZ-UHFFFAOYSA-N 2-phosphonooxyethyl prop-2-enoate Chemical compound OP(O)(=O)OCCOC(=O)C=C UDXXYUDJOHIIDZ-UHFFFAOYSA-N 0.000 description 1
- YFLAJEAQOBRXIK-UHFFFAOYSA-N 2-prop-2-enoyloxyethylphosphonic acid Chemical compound OP(O)(=O)CCOC(=O)C=C YFLAJEAQOBRXIK-UHFFFAOYSA-N 0.000 description 1
- OPZLDVPRAIERSE-UHFFFAOYSA-N 3-[4-[2-[4-[3-(2-methylprop-2-enoyloxy)propoxy]phenyl]propan-2-yl]phenoxy]propyl 2-methylprop-2-enoate Chemical compound C1=CC(OCCCOC(=O)C(=C)C)=CC=C1C(C)(C)C1=CC=C(OCCCOC(=O)C(C)=C)C=C1 OPZLDVPRAIERSE-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 1
- XOJWAAUYNWGQAU-UHFFFAOYSA-N 4-(2-methylprop-2-enoyloxy)butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCOC(=O)C(C)=C XOJWAAUYNWGQAU-UHFFFAOYSA-N 0.000 description 1
- JTEUUUADXRPGAJ-UHFFFAOYSA-N 4-amino-2-prop-2-enoylbenzoic acid Chemical compound NC1=CC=C(C(O)=O)C(C(=O)C=C)=C1 JTEUUUADXRPGAJ-UHFFFAOYSA-N 0.000 description 1
- FUUZAKLLHPPMFZ-UHFFFAOYSA-N 4-amino-2-prop-2-enoyloxybenzoic acid Chemical compound NC1=CC=C(C(O)=O)C(OC(=O)C=C)=C1 FUUZAKLLHPPMFZ-UHFFFAOYSA-N 0.000 description 1
- IRQWEODKXLDORP-UHFFFAOYSA-N 4-ethenylbenzoic acid Chemical compound OC(=O)C1=CC=C(C=C)C=C1 IRQWEODKXLDORP-UHFFFAOYSA-N 0.000 description 1
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 1
- UZDMJPAQQFSMMV-UHFFFAOYSA-N 4-oxo-4-(2-prop-2-enoyloxyethoxy)butanoic acid Chemical compound OC(=O)CCC(=O)OCCOC(=O)C=C UZDMJPAQQFSMMV-UHFFFAOYSA-N 0.000 description 1
- WIYVVIUBKNTNKG-UHFFFAOYSA-N 6,7-dimethoxy-3,4-dihydronaphthalene-2-carboxylic acid Chemical compound C1CC(C(O)=O)=CC2=C1C=C(OC)C(OC)=C2 WIYVVIUBKNTNKG-UHFFFAOYSA-N 0.000 description 1
- SAPGBCWOQLHKKZ-UHFFFAOYSA-N 6-(2-methylprop-2-enoyloxy)hexyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCOC(=O)C(C)=C SAPGBCWOQLHKKZ-UHFFFAOYSA-N 0.000 description 1
- UNLGHUTUQNFLSO-UHFFFAOYSA-N 6-phosphonooxyhexyl prop-2-enoate Chemical compound OP(O)(=O)OCCCCCCOC(=O)C=C UNLGHUTUQNFLSO-UHFFFAOYSA-N 0.000 description 1
- RZVHIXYEVGDQDX-UHFFFAOYSA-N 9,10-anthraquinone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C(=O)C2=C1 RZVHIXYEVGDQDX-UHFFFAOYSA-N 0.000 description 1
- 229940076442 9,10-anthraquinone Drugs 0.000 description 1
- YYVYAPXYZVYDHN-UHFFFAOYSA-N 9,10-phenanthroquinone Chemical compound C1=CC=C2C(=O)C(=O)C3=CC=CC=C3C2=C1 YYVYAPXYZVYDHN-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- ADDLYTSLTXEONX-UHFFFAOYSA-N C(CCCCCCCCC)(C(=O)O)C(=O)O.C(C=C)(=O)OC(C=C)=O Chemical compound C(CCCCCCCCC)(C(=O)O)C(=O)O.C(C=C)(=O)OC(C=C)=O ADDLYTSLTXEONX-UHFFFAOYSA-N 0.000 description 1
- BHSYNZHPRQRMAS-UHFFFAOYSA-N C=CC(=O)OCCCCCCCCCCOP(=O)(CC(=O)O)O Chemical compound C=CC(=O)OCCCCCCCCCCOP(=O)(CC(=O)O)O BHSYNZHPRQRMAS-UHFFFAOYSA-N 0.000 description 1
- QDLCVNMMJAWMOU-UHFFFAOYSA-N C=CC(CCCCCCOC(CCP(O)(O)=O)=O)=O Chemical compound C=CC(CCCCCCOC(CCP(O)(O)=O)=O)=O QDLCVNMMJAWMOU-UHFFFAOYSA-N 0.000 description 1
- NQPMXQYICXIABK-UHFFFAOYSA-N C=CC(CCCCCCOP(CC(O)=O)(O)=O)=O Chemical compound C=CC(CCCCCCOP(CC(O)=O)(O)=O)=O NQPMXQYICXIABK-UHFFFAOYSA-N 0.000 description 1
- JZQGZNFYORBABY-UHFFFAOYSA-N CCC(C=CC=C1)=C1P(O)(OOC(C=C)=O)=O Chemical compound CCC(C=CC=C1)=C1P(O)(OOC(C=C)=O)=O JZQGZNFYORBABY-UHFFFAOYSA-N 0.000 description 1
- ARYCLOFKVLARTR-UHFFFAOYSA-N CCCCCCCCCCC(C(C=C)=O)(C(O)=O)C(O)=O Chemical compound CCCCCCCCCCC(C(C=C)=O)(C(O)=O)C(O)=O ARYCLOFKVLARTR-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- XVZXOLOFWKSDSR-UHFFFAOYSA-N Cc1cc(C)c([C]=O)c(C)c1 Chemical group Cc1cc(C)c([C]=O)c(C)c1 XVZXOLOFWKSDSR-UHFFFAOYSA-N 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000005058 Isophorone diisocyanate Substances 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- LZCXCXDOGAEFQX-UHFFFAOYSA-N N-Acryloylglycine Chemical compound OC(=O)CNC(=O)C=C LZCXCXDOGAEFQX-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 1
- LCXXNKZQVOXMEH-UHFFFAOYSA-N Tetrahydrofurfuryl methacrylate Chemical compound CC(=C)C(=O)OCC1CCCO1 LCXXNKZQVOXMEH-UHFFFAOYSA-N 0.000 description 1
- OKKRPWIIYQTPQF-UHFFFAOYSA-N Trimethylolpropane trimethacrylate Chemical compound CC(=C)C(=O)OCC(CC)(COC(=O)C(C)=C)COC(=O)C(C)=C OKKRPWIIYQTPQF-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- PRRGXULZOZTZDK-UHFFFAOYSA-N [(2,6-dichlorobenzoyl)-(2,5-dimethylphenyl)phosphoryl]-(2,6-dichlorophenyl)methanone Chemical compound CC1=CC=C(C)C(P(=O)(C(=O)C=2C(=CC=CC=2Cl)Cl)C(=O)C=2C(=CC=CC=2Cl)Cl)=C1 PRRGXULZOZTZDK-UHFFFAOYSA-N 0.000 description 1
- ZEDSKTISNTXEQI-UHFFFAOYSA-N [(2,6-dichlorobenzoyl)-(4-propylphenyl)phosphoryl]-(2,6-dichlorophenyl)methanone Chemical compound C1=CC(CCC)=CC=C1P(=O)(C(=O)C=1C(=CC=CC=1Cl)Cl)C(=O)C1=C(Cl)C=CC=C1Cl ZEDSKTISNTXEQI-UHFFFAOYSA-N 0.000 description 1
- YNJCLWHSZGZEAS-UHFFFAOYSA-N [(2,6-dichlorobenzoyl)-naphthalen-1-ylphosphoryl]-(2,6-dichlorophenyl)methanone Chemical compound ClC1=CC=CC(Cl)=C1C(=O)P(=O)(C=1C2=CC=CC=C2C=CC=1)C(=O)C1=C(Cl)C=CC=C1Cl YNJCLWHSZGZEAS-UHFFFAOYSA-N 0.000 description 1
- DNRISHWSPBDRTH-UHFFFAOYSA-N [(2,6-dichlorobenzoyl)-phenylphosphoryl]-(2,6-dichlorophenyl)methanone Chemical compound ClC1=CC=CC(Cl)=C1C(=O)P(=O)(C=1C=CC=CC=1)C(=O)C1=C(Cl)C=CC=C1Cl DNRISHWSPBDRTH-UHFFFAOYSA-N 0.000 description 1
- ULQMPOIOSDXIGC-UHFFFAOYSA-N [2,2-dimethyl-3-(2-methylprop-2-enoyloxy)propyl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(C)(C)COC(=O)C(C)=C ULQMPOIOSDXIGC-UHFFFAOYSA-N 0.000 description 1
- VSXPEHGZLDNBNU-UHFFFAOYSA-N [2,3,5,6-tetraethoxy-4-[2-[2,3,5,6-tetraethoxy-4-(2-methylprop-2-enoyloxy)phenyl]propan-2-yl]phenyl] 2-methylprop-2-enoate Chemical compound CCOC1=C(OC(=O)C(C)=C)C(OCC)=C(OCC)C(C(C)(C)C=2C(=C(OCC)C(OC(=O)C(C)=C)=C(OCC)C=2OCC)OCC)=C1OCC VSXPEHGZLDNBNU-UHFFFAOYSA-N 0.000 description 1
- PRKBXVCDDSZBAG-UHFFFAOYSA-N [2,3-diethoxy-4-[2-[2,3,5-triethoxy-4-(2-methylprop-2-enoyloxy)phenyl]propyl]phenyl] 2-methylprop-2-enoate Chemical compound CCOC1=C(OC(=O)C(C)=C)C(OCC)=CC(C(C)CC=2C(=C(OCC)C(OC(=O)C(C)=C)=CC=2)OCC)=C1OCC PRKBXVCDDSZBAG-UHFFFAOYSA-N 0.000 description 1
- FSDJQMOZRWOIRG-UHFFFAOYSA-N [2,3-dipropoxy-4-[2-[2,3,5-triethoxy-4-(2-methylprop-2-enoyloxy)phenyl]propyl]phenyl] 2-methylprop-2-enoate Chemical compound C1=CC(OC(=O)C(C)=C)=C(OCCC)C(OCCC)=C1CC(C)C1=CC(OCC)=C(OC(=O)C(C)=C)C(OCC)=C1OCC FSDJQMOZRWOIRG-UHFFFAOYSA-N 0.000 description 1
- JUDXBRVLWDGRBC-UHFFFAOYSA-N [2-(hydroxymethyl)-3-(2-methylprop-2-enoyloxy)-2-(2-methylprop-2-enoyloxymethyl)propyl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(CO)(COC(=O)C(C)=C)COC(=O)C(C)=C JUDXBRVLWDGRBC-UHFFFAOYSA-N 0.000 description 1
- QZTORBFYQVRJKY-UHFFFAOYSA-N [2-hydroxy-3-[2-[2-[2-[2-hydroxy-3-(2-methylprop-2-enoyloxy)propoxy]phenyl]propan-2-yl]phenoxy]propyl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)COC1=CC=CC=C1C(C)(C)C1=CC=CC=C1OCC(O)COC(=O)C(C)=C QZTORBFYQVRJKY-UHFFFAOYSA-N 0.000 description 1
- SWHLOXLFJPTYTL-UHFFFAOYSA-N [2-methyl-3-(2-methylprop-2-enoyloxy)-2-(2-methylprop-2-enoyloxymethyl)propyl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(C)(COC(=O)C(C)=C)COC(=O)C(C)=C SWHLOXLFJPTYTL-UHFFFAOYSA-N 0.000 description 1
- FOVRCPBDDCLNIG-UHFFFAOYSA-N [3-(2-methylprop-2-enoyloxy)-2-(2-methylprop-2-enoyloxymethyl)propyl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(COC(=O)C(C)=C)COC(=O)C(C)=C FOVRCPBDDCLNIG-UHFFFAOYSA-N 0.000 description 1
- ZQXXOHLLRULDPZ-UHFFFAOYSA-N [3-oxo-3-(3-prop-2-enoyloxypropoxy)propyl]phosphonic acid Chemical compound C(C=C)(=O)OCCCOC(CCP(=O)(O)O)=O ZQXXOHLLRULDPZ-UHFFFAOYSA-N 0.000 description 1
- ONGHDSJUXYRYOZ-UHFFFAOYSA-N [3-oxo-3-(4-prop-2-enoyloxybutoxy)propyl]phosphonic acid Chemical compound C(C=C)(=O)OCCCCOC(CCP(=O)(O)O)=O ONGHDSJUXYRYOZ-UHFFFAOYSA-N 0.000 description 1
- MRCMTIRVXOVDMR-UHFFFAOYSA-N [3-oxo-3-(5-prop-2-enoyloxypentoxy)propyl]phosphonic acid Chemical compound OP(O)(=O)CCC(=O)OCCCCCOC(=O)C=C MRCMTIRVXOVDMR-UHFFFAOYSA-N 0.000 description 1
- UUQJMSSFMULZHR-UHFFFAOYSA-N [4,5,5,6,6-pentaethoxy-4-[2-[1,5,5,6,6-pentaethoxy-4-(2-methylprop-2-enoyloxy)cyclohex-2-en-1-yl]propan-2-yl]cyclohex-2-en-1-yl] 2-methylprop-2-enoate Chemical compound C(C(=C)C)(=O)OC1C(C(C(C=C1)(C(C)(C)C1(C(C(C(C=C1)OC(C(=C)C)=O)(OCC)OCC)(OCC)OCC)OCC)OCC)(OCC)OCC)(OCC)OCC UUQJMSSFMULZHR-UHFFFAOYSA-N 0.000 description 1
- SJSXBTSSSQCODU-UHFFFAOYSA-N [4-[2-[2,3-diethoxy-4-(2-methylprop-2-enoyloxy)phenyl]propan-2-yl]-2,3-diethoxyphenyl] 2-methylprop-2-enoate Chemical compound CCOC1=C(OC(=O)C(C)=C)C=CC(C(C)(C)C=2C(=C(OCC)C(OC(=O)C(C)=C)=CC=2)OCC)=C1OCC SJSXBTSSSQCODU-UHFFFAOYSA-N 0.000 description 1
- RRXMSCIBDRKLQO-UHFFFAOYSA-N [4-[2-[4-(2-methylprop-2-enoyloxy)-2,3-dipropoxyphenyl]propan-2-yl]-2,3-dipropoxyphenyl] 2-methylprop-2-enoate Chemical compound CCCOC1=C(OC(=O)C(C)=C)C=CC(C(C)(C)C=2C(=C(OCCC)C(OC(=O)C(C)=C)=CC=2)OCCC)=C1OCCC RRXMSCIBDRKLQO-UHFFFAOYSA-N 0.000 description 1
- NUJYRWXNUFEUHQ-UHFFFAOYSA-N [4-[2-[4-(2-methylprop-2-enoyloxy)-2-propan-2-yloxyphenyl]propan-2-yl]-3-propan-2-yloxyphenyl] 2-methylprop-2-enoate Chemical compound CC(C)OC1=CC(OC(=O)C(C)=C)=CC=C1C(C)(C)C1=CC=C(OC(=O)C(C)=C)C=C1OC(C)C NUJYRWXNUFEUHQ-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001339 alkali metal compounds Chemical class 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 239000005354 aluminosilicate glass Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- UIJGNTRUPZPVNG-UHFFFAOYSA-N benzenecarbothioic s-acid Chemical compound SC(=O)C1=CC=CC=C1 UIJGNTRUPZPVNG-UHFFFAOYSA-N 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- ZWPWLKXZYNXATK-UHFFFAOYSA-N bis(4-methylphenyl)methanone Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=C(C)C=C1 ZWPWLKXZYNXATK-UHFFFAOYSA-N 0.000 description 1
- QUZSUMLPWDHKCJ-UHFFFAOYSA-N bisphenol A dimethacrylate Chemical compound C1=CC(OC(=O)C(=C)C)=CC=C1C(C)(C)C1=CC=C(OC(=O)C(C)=C)C=C1 QUZSUMLPWDHKCJ-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- 229930006711 bornane-2,3-dione Natural products 0.000 description 1
- 239000005388 borosilicate glass Substances 0.000 description 1
- YHWCPXVTRSHPNY-UHFFFAOYSA-N butan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCC[O-].CCCC[O-].CCCC[O-].CCCC[O-] YHWCPXVTRSHPNY-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000003479 dental cement Substances 0.000 description 1
- ISAOCJYIOMOJEB-UHFFFAOYSA-N desyl alcohol Natural products C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 125000005520 diaryliodonium group Chemical group 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- HFJRKMMYBMWEAD-UHFFFAOYSA-N dodecanal Chemical compound CCCCCCCCCCCC=O HFJRKMMYBMWEAD-UHFFFAOYSA-N 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- ZJXZSIYSNXKHEA-UHFFFAOYSA-N ethyl dihydrogen phosphate Chemical compound CCOP(O)(O)=O ZJXZSIYSNXKHEA-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000002241 glass-ceramic Substances 0.000 description 1
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 1
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 description 1
- 229910021480 group 4 element Inorganic materials 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910052809 inorganic oxide Inorganic materials 0.000 description 1
- 239000010954 inorganic particle Substances 0.000 description 1
- 229940035429 isobutyl alcohol Drugs 0.000 description 1
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 229940089454 lauryl aldehyde Drugs 0.000 description 1
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 1
- FUJCRWPEOMXPAD-UHFFFAOYSA-N lithium oxide Chemical compound [Li+].[Li+].[O-2] FUJCRWPEOMXPAD-UHFFFAOYSA-N 0.000 description 1
- 229910001947 lithium oxide Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 229910001512 metal fluoride Inorganic materials 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- CRVGTESFCCXCTH-UHFFFAOYSA-N methyl diethanolamine Chemical compound OCCN(C)CCO CRVGTESFCCXCTH-UHFFFAOYSA-N 0.000 description 1
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000012766 organic filler Substances 0.000 description 1
- 150000003961 organosilicon compounds Chemical class 0.000 description 1
- WKGDNXBDNLZSKC-UHFFFAOYSA-N oxido(phenyl)phosphanium Chemical compound O=[PH2]c1ccccc1 WKGDNXBDNLZSKC-UHFFFAOYSA-N 0.000 description 1
- FZUGPQWGEGAKET-UHFFFAOYSA-N parbenate Chemical compound CCOC(=O)C1=CC=C(N(C)C)C=C1 FZUGPQWGEGAKET-UHFFFAOYSA-N 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NPUSTSBKXOLJIC-UHFFFAOYSA-N phenyl(2-prop-2-enoyloxyethoxy)phosphinic acid Chemical compound C=CC(=O)OCCOP(=O)(C1=CC=CC=C1)O NPUSTSBKXOLJIC-UHFFFAOYSA-N 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- BOQSSGDQNWEFSX-UHFFFAOYSA-N propan-2-yl 2-methylprop-2-enoate Chemical compound CC(C)OC(=O)C(C)=C BOQSSGDQNWEFSX-UHFFFAOYSA-N 0.000 description 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000000790 scattering method Methods 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000012756 surface treatment agent Substances 0.000 description 1
- KUCOHFSKRZZVRO-UHFFFAOYSA-N terephthalaldehyde Chemical compound O=CC1=CC=C(C=O)C=C1 KUCOHFSKRZZVRO-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229910000309 titanium group oxide Inorganic materials 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- JLGLQAWTXXGVEM-UHFFFAOYSA-N triethylene glycol monomethyl ether Chemical compound COCCOCCOCCO JLGLQAWTXXGVEM-UHFFFAOYSA-N 0.000 description 1
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000012463 white pigment Substances 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
- 229940105963 yttrium fluoride Drugs 0.000 description 1
- RBORBHYCVONNJH-UHFFFAOYSA-K yttrium(iii) fluoride Chemical compound F[Y](F)F RBORBHYCVONNJH-UHFFFAOYSA-K 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Landscapes
- Dental Preparations (AREA)
Abstract
Description
本発明は、歯科用硬化性組成物に関する。詳しくは、使用の簡便性が高く且つ審美性に優れた歯科用充填修復材料として好適な歯科用硬化性組成物に関する。 The present invention relates to a dental curable composition. More specifically, the present invention relates to a dental curable composition suitable as a dental filling restoration material having high convenience of use and excellent aesthetics.
歯科用コンポジットレジン(以下、単に「CR」ともいう。)とは、齲蝕や破折等により損傷をうけた歯牙の修復をするための材料の一種であり、重合性単量体と、無機及び/又は有機のフィラーとを含む硬化性組成物からなる。歯科用コンポジットレジン(CR)を用いた修復(CR修復)は、歯質の切削量を少なくでき、天然歯牙色と同等の色調を付与できることや操作が容易なことから、急速に普及している。また、近年においては、機械的強度の向上や、歯牙との接着力の向上から、前歯部の修復のみならず、高い咬合圧が加わる臼歯部に対しても使用されている。 Dental composite resin (hereinafter, also simply referred to as "CR") is a type of material for repairing teeth damaged by caries, fracture, etc., and is a type of material for repairing teeth that have been damaged by caries, fracture, etc. / Or consists of a curable composition containing an organic filler. Restoration using dental composite resin (CR) (CR restoration) is rapidly becoming widespread because it can reduce the amount of cutting of the tooth substance, give a color tone equivalent to that of natural tooth color, and is easy to operate. .. Further, in recent years, it has been used not only for restoration of the anterior tooth portion but also for the molar tooth portion to which a high occlusal pressure is applied because of the improvement of mechanical strength and the improvement of the adhesive force with the tooth.
上記したように審美性の高い修復が可能であることがCR修復の優れた特徴の一つであるが、天然歯は、象牙質およびエナメル質からなり、各部位で色調(色相、彩度、明度)が異なるため、審美性の高い修復を行うためには、修復する歯牙(被修復歯牙)の状態に応じてきめの細かい対応が必要となる。たとえば、修復歯牙の損傷が軽く、窩洞が浅い場合でも、色調が各異なるCRを複数種用意し、この中から、実際の修復歯牙及びその隣接歯牙(以下、「修復歯牙の周辺」とも言う。)と色調が最も良く適合したものを選定して使うことが一般に行われている(非特許文献1参照)。また、窩洞が深いと、歯牙の色調は、単に歯面部(エナメル質部分)の色調だけでなく、透けて見える深層部(象牙質部分)までの色調も融合してグラデーションに富む状態で観取されるため、一定の深さごとに、充填する硬化性ペーストの色調を変え、積層充填して、この微妙な色調を再現している(非特許文献1及び非特許文献2参照)。 As mentioned above, one of the excellent features of CR restoration is that it can be restored with high aesthetics. Natural teeth are composed of dentin and enamel, and each part has a color tone (hue, saturation, etc.). Since the brightness) is different, in order to perform highly aesthetic restoration, it is necessary to take detailed measures according to the condition of the tooth to be restored (tooth to be restored). For example, even if the repaired tooth is lightly damaged and the tooth cavity is shallow, a plurality of CRs having different color tones are prepared, and the actual repaired tooth and its adjacent tooth (hereinafter, also referred to as "around the repaired tooth"). ) And the one with the best color tone are generally selected and used (see Non-Patent Document 1). In addition, when the tooth cavity is deep, the color tone of the tooth is not only the color tone of the tooth surface (enamel part) but also the color tone of the deep part (dentin part) that can be seen through, and it is viewed in a state rich in gradation. Therefore, the color tone of the curable paste to be filled is changed for each constant depth, and this delicate color tone is reproduced by laminating and filling (see Non-Patent Document 1 and Non-Patent Document 2).
このような要求に応えるため、顔料物質や染料物質を、その種類や配合量を変えて添加することによって、色調が調製された多くのCRが提供されている。ところが、顔料物質や染料物質を用いて色調調整を行ったCRには、CR硬化体中におけるこれら物質が経年劣化によって退色または変色することにより、修復後から時間が経過するに従って変色し、修復部位の外観が天然歯と適合しなくなってしまうことがある。 In order to meet such demands, many CRs whose color tone is prepared by adding pigment substances and dye substances in different types and blending amounts are provided. However, in CR whose color tone has been adjusted using a pigment substance or a dye substance, these substances in the CR cured product fade or discolor due to aged deterioration, so that the color changes as time passes after the restoration, and the repaired portion. The appearance of the tooth may not match the natural tooth.
一方、顔料物質や染料物質を用いずに着色する技術として、媒質中の微粒子による光の反射、干渉、散乱、透過など利用した着色光(以下、単に「干渉光」ともいう。)により発色を生じさせる技術があり(以下、このような原理で発現する色を「構造色」ともいう。)、これら技術を応用して樹脂などの媒体中に無機粒子が分散した複合材料を所期の色に発色させる技術も知られている(特許文献1参照)。 On the other hand, as a technique for coloring without using a pigment substance or a dye substance, coloring is performed by coloring light (hereinafter, also simply referred to as "interference light") using reflection, interference, scattering, transmission, etc. of light by fine particles in a medium. There is a technique to generate it (hereinafter, the color expressed by such a principle is also referred to as "structural color"), and by applying these techniques, a composite material in which inorganic particles are dispersed in a medium such as a resin is the desired color. A technique for developing a color is also known (see Patent Document 1).
すなわち特許文献1には、たとえば、「重合性単量体成分(A),平均粒子径が230nm〜1000nmの範囲内にある無機球状フィラー(B)及び重合開始剤(C)を含み、前記無機球状フィラー(B)を構成する個々の粒子のうち90%以上が平均粒子径の前後の5%の範囲内に存在し、前記無機球状フィラー(B)の25℃における屈折率nFが前記重合性単量体成分(A)を重合して得られる重合体の25℃における屈折率nPよりも大きいという条件を満足する硬化性組成物」からなり、「厚さ1mmの硬化体を形成した状態で、各々色差計を用いて測定した、黒背景下での着色光のマンセル表色系による測色値の明度(V)が5未満であり、彩度(C)が0.05以上であり、且つ白背景下での着色光のマンセル表色系による測色値の明度(V)が6以上であり、彩度(C)が2未満となる硬化性組成物」が開示されている。そして、特許文献1には上記硬化性組成物からなるCRは、(1)染料物質や顔料物質を用いていないので前記経時変色の問題が起こり難く、(2)(使用する無機球状フィラーの平均粒子径に応じて)象牙色質と同様の色である黄色〜赤色に着色することができ、しかも(3)硬化体が被修復歯牙の色と調和し易く、煩雑なシェードテイキングやコンポジットレジンのシェード選択を行うことなく、1種類のコンポジットレジンで広範な色の被修復歯牙に対して天然歯に近い外観の修復を行うことができる、という優れた特徴を有することが記載されている。なお、特許文献1に開示されている硬化性組成物は、深層部に象牙質が位置する窩洞の修復を主目的として黄色〜赤色系の着色光を発現するように設計されたものであるため、無機球状フィラー(B)として平均粒子径が230nm以上のものを用いているが、青色系を含めて、その色調にこだわらなければ構造色自体は平均粒子径が100nm以上のものを用いることができる。 That is, Patent Document 1 includes, for example, "a polymerizable monomer component (A), an inorganic spherical filler (B) having an average particle size in the range of 230 nm to 1000 nm, and a polymerization initiator (C). more than 90% of the individual particles constituting the spherical filler (B) is present in the range of 5% before and after the average particle diameter, refractive index n F in the 25 ° C. of inorganic spherical filler (B) is a polymer consists sex monomer component curable composition which satisfies the condition that is greater than the refractive index n P at 25 ° C. of the polymer obtained by polymerizing (a) ", to form a cured body of the" thickness 1mm In the state, the brightness (V) of the colorimetric value measured by the Mansell color system of the colored light under the black background measured using the color difference meter is less than 5, and the saturation (C) is 0.05 or more. There is disclosed a curable composition in which the lightness (V) of the colorimetric value measured by the Mansell color system of the colored light under a white background is 6 or more and the saturation (C) is less than 2. .. Further, in Patent Document 1, since the CR composed of the curable composition does not use (1) a dye substance or a pigment substance, the problem of discoloration with time is unlikely to occur, and (2) (the average of the inorganic spherical fillers used). It can be colored yellow to red, which is the same color as ivory color (depending on the particle size), and (3) the cured product easily matches the color of the tooth to be restored, and it is a complicated shade-taking or composite resin. It is described that one type of composite resin has an excellent feature that it is possible to restore the appearance of a wide range of colors of teeth to be restored, which is close to that of natural teeth, without performing shade selection. The curable composition disclosed in Patent Document 1 is designed to emit yellow to red colored light mainly for the purpose of repairing the tooth cavity in which dentin is located in the deep layer. As the inorganic spherical filler (B), one having an average particle diameter of 230 nm or more is used, but if the color tone is not particular, including the bluish color, the structural color itself may be one having an average particle diameter of 100 nm or more. it can.
特許文献1に開示されている硬化性組成物は、CRとして使用した時に前記したような優れた特徴を発揮するものである。ところが、該硬化性組成物は、前記したように深層部に象牙質が位置する窩洞の修復を主目的として設計されたものであり、深層部に象牙質が存在しないようなIII級窩洞(前歯の隣接面窩洞で切縁隅角を含まない窩洞)やIV級窩洞(前歯の隣接面窩洞で切縁隅角を含む窩洞)の修復に用いた場合の色調適合性については検討されていない。 The curable composition disclosed in Patent Document 1 exhibits the above-mentioned excellent characteristics when used as a CR. However, the curable composition was designed mainly for the purpose of repairing the tooth cavity in which dentin is located in the deep layer as described above, and is a class III cavity (anterior tooth) in which dentin is not present in the deep layer. Color compatibility has not been investigated when used to repair (adjacent dentin without dentin) or class IV dentin (adjacent dentin of anterior teeth with dentin).
そこで、本発明者らが特許文献1に開示されている硬化性組成物の前歯部(III級窩洞やIV級窩洞)の修復における色調適合性について検討を行ったところ、干渉光により構造色は発現するものの、おそらく硬化体の透明性が高過ぎて、反射光や散乱光が観察者に到達し難くなることが原因と思われるが、修復部が黒っぽく見えてしまう(発現した構造色が目視で認識できない)ことがあると明らかとなった。このような現象は、修復部に層構造を導入し、下地部(修復歯牙の裏側近傍に相当する部分)に透明性の低いCRの硬化体を配置し、表層部(修復歯牙の前面側)に前記硬化性組成物からなるCRを配置するようにすれば解決できると考えられるが、操作が煩雑となることが避けられない。 Therefore, when the present inventors examined the color tone compatibility in the restoration of the anterior tooth portion (class III cavity and class IV cavity) of the curable composition disclosed in Patent Document 1, the structural color was changed by the interference light. Although it appears, it is probably because the cured product is too transparent and it is difficult for reflected light and scattered light to reach the observer, but the repaired part looks blackish (the developed structural color is visible). It became clear that there are some cases that cannot be recognized. In such a phenomenon, a layered structure is introduced in the restoration part, a cured body of CR with low transparency is placed in the base part (the part corresponding to the vicinity of the back side of the restoration tooth), and the surface layer part (the front side of the restoration tooth). It is considered that the problem can be solved by arranging the CR made of the curable composition in the above, but it is inevitable that the operation becomes complicated.
本発明は、上記したような、構造色による色調調整を行うCRに特有の課題であって、これまで認識されていなかった上記課題を解決し、顔料物質や染料物質を用いることなく、III級窩洞やIV級窩洞の修復に用いた場合であっても高い色調適合性を得られ、CRとして使用可能な歯科用硬化性組成物を提供することを目的とする。 The present invention solves the above-mentioned problems peculiar to CR that adjusts the color tone by structural color, which has not been recognized so far, and is class III without using a pigment substance or a dye substance. It is an object of the present invention to provide a dental curable composition which can obtain high color compatibility even when used for repairing a cavity or a class IV cavity and can be used as a CR.
本発明者らは、引用文献1に開示されている硬化性組成物について、その構造色発現機能を保持したまま、得られる硬化体の透明性を低下させることができれば前記課題を解決することができると考え、鋭意検討を行った。その結果、(1)CRに含まれる重合性単量体を重合して得られる重合体の屈折率と同一もしくはわずかに高い屈折率を有する、平均一次粒子径が1000nmを超え3000nm未満の範囲内にある不定形無機フィラーを配合することにより硬化体の透明性を低くすることができること、(2)その時の透明性は、上記不定形無機フィラーの配合量により調整可能であること、(3)前記不定形フィラーの添加により透明性を低下させた場合には、その低下の度合いが強くなるに従って、発現する構造色が認識し難くなること、及び(4)前記(2)の知見に基づき不透明性を適度に調節した場合には、発現する構造色について視認性を保持でき、前記課題を解決することができることを見出し、本発明を完成するに至った。 The present inventors can solve the above-mentioned problems with respect to the curable composition disclosed in Cited Document 1 if the transparency of the obtained cured product can be reduced while maintaining the structural color expression function. I thought that I could do it, and conducted a diligent study. As a result, (1) the average primary particle size is in the range of more than 1000 nm and less than 3000 nm, which has the same or slightly higher refractive index as the refractive index of the polymer obtained by polymerizing the polymerizable monomer contained in CR. The transparency of the cured product can be lowered by blending the amorphous inorganic filler in (2), and the transparency at that time can be adjusted by the blending amount of the amorphous inorganic filler in (3). When the transparency is lowered by the addition of the amorphous filler, the structural color to be developed becomes difficult to recognize as the degree of the reduction becomes stronger, and (4) it is opaque based on the findings of (2) above. We have found that when the sex is appropriately adjusted, the visibility of the expressed structural color can be maintained and the above-mentioned problems can be solved, and the present invention has been completed.
すなわち、第一の本発明は、 重合性単量体成分(A)、平均一次粒子径が100nm以上1000nm以下の範囲内にあり、個数基準粒度分布において全粒子数の90%以上が前記平均一次粒子径の前後の5%の範囲に存在する無機球状フィラー(B)、1000nmを超え3000nm未満の範囲内にある不定形無機フィラー(C)及び重合開始剤(D)を含んでなる歯科用硬化性組成物であって、前記重合性単量体成分(A)を重合して得られる重合体の25℃における屈折率をnPとし、前記無機球状フィラー(B)の25℃における屈折率をnFBとし、前記不定形無機フィラー(C)の25℃における屈折率をnFCとしたときに、 nFB>nP であり、且つ 0.000≦nFC−nP≦0.002 である、ことを特徴とする歯科用硬化性組成物である。 That is, in the first invention, the polymerizable monomer component (A) has an average primary particle diameter in the range of 100 nm or more and 1000 nm or less, and 90% or more of the total number of particles in the number-based particle size distribution is the average primary particle. Dental curing comprising an inorganic spherical filler (B) present in a range of 5% before and after the particle size, an amorphous inorganic filler (C) in a range of more than 1000 nm and less than 3000 nm, and a polymerization initiator (D). The refractive index of the polymer obtained by polymerizing the polymerizable monomer component (A) in the sex composition at 25 ° C. is n P, and the refractive index of the inorganic spherical filler (B) at 25 ° C. is defined as nP. When n FB and the refractive index of the amorphous inorganic filler (C) at 25 ° C. are n FC , n FB > n P and 0.000 ≦ n FC −n P ≦ 0.002. , A dental curable composition.
上記本発明の歯科用硬化性組成物においては、発現する構造色について有効な視認性を保持できるという観点から、本発明の歯科用硬化性組成物を硬化させて得られる厚さ1mmの硬化体について色差計を用いて測定した、黒背景下での分光反射率曲線において、600nm以上750nm以下の波長領域(黄色〜赤色域)内における分光反射率の最大値:SR1を、400nm以上500nm以下の波長領域(青色域)内における分光反射率の最大値:SR2で除した値として定義される分光反射率比:SR1/SR2が0.8以上2.0以下の範囲、特に0.9以上1.5以下の範囲となるものであることが好ましい。また、黄色から赤色の構造色を高強度で発現するという観点から、前記無機球状フィラー(B)の平均一次粒子径が230nm以上350nm以下、特に245nm以上300nm以下であることが好ましく、また、前記重合性単量体(A)100質量部に対する前記無機球状フィラー(B)と前記不定形無機フィラー(C)との合計配合量が100質量部以上1500質量部以下であり、当該合計配合量に占める前記不定形無機フィラー(C)の配合量の割合が5%以上30%以下であることが好ましい。また、本発明の歯科用硬化性組成物の硬化体によってIII級窩洞やIV級窩洞を修復したときの修復部の色調適合性がより高くなるという観点から、厚さ1mmの硬化体について、背景を黒色及び白色とした色差計による三刺激値測定で決定されるY刺激値を夫々Yb(黒色背景)及びYw(白色背景)としたときの両者の比:Yb/Ywで定義されるコントラスト比が0.30〜0.70、特に0.4〜0.6である硬化体を与えるものであることが好ましい。 In the above-mentioned dental curable composition of the present invention, a cured product having a thickness of 1 mm obtained by curing the dental curable composition of the present invention from the viewpoint of maintaining effective visibility of the developed structural color. In the spectral reflectance curve under a black background measured using a color difference meter, the maximum value of the spectral reflectance in the wavelength region (yellow to red region) of 600 nm or more and 750 nm or less: SR 1 is 400 nm or more and 500 nm or less. Maximum value of spectral reflectance in the wavelength region (blue region) of: The spectral reflectance ratio defined as the value divided by SR 2 : SR 1 / SR 2 is in the range of 0.8 or more and 2.0 or less, especially 0. It is preferably in the range of 0.9 or more and 1.5 or less. Further, from the viewpoint of developing a structural color from yellow to red with high intensity, the average primary particle size of the inorganic spherical filler (B) is preferably 230 nm or more and 350 nm or less, particularly preferably 245 nm or more and 300 nm or less. The total blending amount of the inorganic spherical filler (B) and the amorphous inorganic filler (C) with respect to 100 parts by mass of the polymerizable monomer (A) is 100 parts by mass or more and 1500 parts by mass or less. The proportion of the amount of the amorphous inorganic filler (C) to be blended is preferably 5% or more and 30% or less. Further, from the viewpoint that the color tone compatibility of the repaired portion is higher when the III-class cavity and the IV-class cavity are repaired by the cured product of the dental curable composition of the present invention, the background of the cured product having a thickness of 1 mm is used. The ratio of the Y stimulus values determined by the tristimulus value measurement by the color difference meter with black and white as Y b (black background) and Y w (white background), respectively: defined by Y b / Y w. It is preferable to give a cured product having a contrast ratio of 0.30 to 0.70, particularly 0.4 to 0.6.
第二の本発明は、前記本発明の歯科用硬化性組成物からなるIII級窩洞及び/又はIV級窩洞修復用の歯科用充填修復材料であり、第三の本発明は、前記本発明の歯科用硬化性組成物の硬化体からなるIII級窩洞及び/又はIV級窩洞修復用歯科材料である。 The second invention is a dental filling restoration material for repairing a class III tooth cavity and / or a class IV tooth cavity composed of the dental curable composition of the present invention, and the third invention is the present invention. A dental material for class III and / or class IV tooth cavity restoration, which comprises a cured product of a dental curable composition.
本発明の歯科用硬化性組成物は、退色の問題の原因となる染料物質や顔料物質を用いることなく、1種類のみで構造色により周囲に調和した色調とすることができるという、前記特許文献1に開示された硬化性組成物と同様の効果を奏するばかりでなく、適度な不透明性を有するため、前歯欠損部の修復、特にIII級窩洞やIV級窩洞の修復においても、下地用のCRを用いることなく、1種類で天然歯牙との色調適合性の高い修復を行うことが可能となる。 The patent document states that the dental curable composition of the present invention can have a color tone that is in harmony with the surroundings by a structural color with only one type without using a dye substance or a pigment substance that causes a problem of fading. Not only does it have the same effect as the curable composition disclosed in 1, but it also has moderate opacity, so it is also used in the repair of anterior tooth defects, especially in the repair of class III and IV cavities. It is possible to perform restoration with high color compatibility with natural teeth with one type without using.
本発明の最大の特徴は、前記特許文献1に開示されるような構造色を発現する硬化性組成物において、平均粒子径が1000nmを超え3000nm未満の範囲内にある不定形無機フィラーであって、当該不定形無機フィラー(C)の25℃における屈折率:nFCとし、前記重合性単量体成分(A)を重合して得られる重合体の25℃における屈折率をnPとしたときに0.000≦nFC−nP≦0.002の関係満たす不定形無機フィラー(C)を配合することによって、得られる硬化体に、発現する構造色の視認性を保つことのできるような適度な不透明性を付与した点にある。このことによって、適度な不透明性を硬化体に付与し、たとえば厚さ1mmの硬化体について、背景を黒色及び白色とした色差計による三刺激値測定で決定されるY刺激値を夫々Yb(黒色背景)及びYw(白色背景)としたときの両者の比:Yb/Ywで定義されるコントラスト比を0.3〜0.7、より好ましくは0.4〜0.6の範囲とすることができる。しかも、このときの不透明性は前記したような干渉光による効果を保持できる程度のものであるので、III級窩洞やIV級窩洞の修復に対しても自然な色調を呈する審美修復が可能となる。 The greatest feature of the present invention is an amorphous inorganic filler having an average particle size of more than 1000 nm and less than 3000 nm in a curable composition that expresses a structural color as disclosed in Patent Document 1. The refractive index of the amorphous inorganic filler (C) at 25 ° C. is n FC, and the refractive index of the polymer obtained by polymerizing the polymerizable monomer component (A) at 25 ° C. is n P. By blending the amorphous inorganic filler (C) satisfying the relationship of 0.000 ≦ n FC −n P ≦ 0.002 in the obtained cured product, the visibility of the structural color to be developed can be maintained. The point is that it gives appropriate opacity. As a result, appropriate opacity is imparted to the cured product, and for example, for a cured product having a thickness of 1 mm, the Y stimulation value determined by the tristimulus value measurement with a color difference meter with a black and white background is set to Y b (each). Ratio of both when it is defined as (black background) and Y w (white background): The contrast ratio defined by Y b / Y w is in the range of 0.3 to 0.7, more preferably 0.4 to 0.6. Can be. Moreover, since the opacity at this time is such that the effect of the interference light as described above can be maintained, it is possible to perform aesthetic restoration that exhibits a natural color tone even for restoration of class III and IV tooth cavities. ..
このように、本発明は、構造色を発現する硬化性組成物をベースとするものであり、そのベースとなる硬化性組成物の基本組成(各成分やその配合量など)や構造色を発現するために満たすべき条件などは前記特許文献1に開示されている硬化性組成物と基本的には同じである。すなわち、本発明の歯科用硬化性組成物は、重合性単量体成分(A)、平均一次粒子径が100nm以上1000nm以下の範囲内にあり、個数基準粒度分布において全粒子数の90%以上が前記平均一次粒子径の前後の5%の範囲に存在する無機球状フィラー(B)、及び重合開始剤(D)を含み、更に、前記無機球状フィラー(B)の25℃における屈折率:nFBは、前記重合性単量体成分(A)を重合して得られる重合体の25℃における屈折率:nPよりも大きい。このような条件を満足することにより、染料物質、顔料物質を用いなくても干渉光、延いてはこれに基づく構造色が明瞭に確認でき、窩洞の深さに関係なく、天然歯に近い、色調適合性の良好な修復が可能となる歯科用硬化性組成物、特に歯科用充填修復材料用の硬化性組成物となる。 As described above, the present invention is based on a curable composition that expresses a structural color, and expresses the basic composition (each component, its blending amount, etc.) and the structural color of the curable composition that is the base thereof. The conditions and the like to be satisfied are basically the same as those of the curable composition disclosed in Patent Document 1. That is, the dental curable composition of the present invention has the polymerizable monomer component (A), the average primary particle size in the range of 100 nm or more and 1000 nm or less, and 90% or more of the total number of particles in the number-based particle size distribution. Contains the inorganic spherical filler (B) and the polymerization initiator (D) present in the range of 5% before and after the average primary particle size, and further, the refractive index of the inorganic spherical filler (B) at 25 ° C.: n The FB is larger than the refractive index at 25 ° C. of the polymer obtained by polymerizing the polymerizable monomer component (A): n P. By satisfying such conditions, the interference light and the structural color based on the interference light can be clearly confirmed without using a dye substance or a pigment substance, and it is close to a natural tooth regardless of the depth of the tooth cavity. It is a dental curable composition capable of restoration with good color compatibility, particularly a curable composition for a dental filling restoration material.
ここで、無機球状フィラー(B)の粒径と光の干渉現象との関係は、ブラッグ回折条件に従うと考えられ、無機球状フィラー(B)の平均一次粒子径に応じた色調の干渉光が発生する(構造色が発現する)。そして、干渉光の発生(構造色の発現)は、色差計を用いた分光反射率を測定することにより確認することができる。ただし、白背景下で測定した場合には、外光(例えばC光源、D65光源)の散乱反射光が強いため干渉による着色光が観察され難くなるので、黒背景下で測定を行う必要がある。黒背景下で測定した場合には、外光が吸収或いは遮光されて発生する干渉光の波長に対応する反射スペクトルを明瞭に確認することができる。なお、前記屈折率の条件を満たさないなどの理由、或いは不定形フィラーのみを添加して無機球状フィラー(B)を添加しないなどの理由により特定色の構造色が発現しない場合に黒背景下で分光反射率測定を行うと、相対的に青色系の反射が強く観測される傾向があり(比較例4〜9の分光反射率比:SR1/SR2参照)、反射スペクトルを見ても青色系の波長領域の強度が黄色〜赤色系の波長領域の強度より有意に高くなるのが通常である。これに対し、前記特許文献1に開示される硬化性組成物では、黄色から赤色の波長領域に極大を有するようになっている。本発明では透明性の低下(不透明性の増大)により構造色の発現性は低下するものの、不透明性は適度に制御されているため、黄色から赤色の波長領域の強度は青色系の波長領域の強度と同等以上のレベルとなり、高い色調適合性を得ることが可能となっている。 Here, the relationship between the particle size of the inorganic spherical filler (B) and the light interference phenomenon is considered to be in accordance with Bragg diffraction conditions, and interference light having a color tone corresponding to the average primary particle size of the inorganic spherical filler (B) is generated. (Structural color appears). Then, the generation of interference light (expression of structural color) can be confirmed by measuring the spectral reflectance using a color difference meter. However, when measured under a white background, it is difficult to observe colored light due to interference because the diffusely reflected light of external light (for example, C light source and D65 light source) is strong, so it is necessary to perform the measurement under a black background. .. When measured under a black background, the reflection spectrum corresponding to the wavelength of the interference light generated by absorbing or blocking external light can be clearly confirmed. In addition, when the structural color of a specific color does not appear due to reasons such as not satisfying the above-mentioned reflectance condition, or reasons such as adding only an amorphous filler and not adding an inorganic spherical filler (B), under a black background. When the spectral reflectance is measured, a relatively strong bluish reflection tends to be observed ( see the spectral reflectance ratio of Comparative Examples 4 to 9: SR 1 / SR 2 ), and the reflection spectrum is also blue. The intensity of the wavelength region of the system is usually significantly higher than the intensity of the wavelength region of the yellow to red system. On the other hand, the curable composition disclosed in Patent Document 1 has a maximum in the wavelength region from yellow to red. In the present invention, although the expression of the structural color decreases due to the decrease in transparency (increase in opacity), the opacity is appropriately controlled, so that the intensity in the yellow to red wavelength region is in the blue wavelength region. The level is equal to or higher than the intensity, and it is possible to obtain high color compatibility.
以下、本発明の歯科用硬化性組成物の各成分について説明する。 Hereinafter, each component of the dental curable composition of the present invention will be described.
<重合性単量体成分(A)>
重合性単量体成分(A)としては、公知のものが特に制限なく使用できる。歯科用途として見た場合、重合速度の観点から、ラジカル重合性、或いはカチオン重合性の単量体が好ましい。特に好ましいラジカル重合性単量体としては(メタ)アクリル化合物である以下に例示する(メタ)アクリレート類が挙げられ、また特に好ましいカチオン重合性単量体としては、エポキシ類、オキセタン類が挙げられる。 一般に、好適に使用される(メタ)アクリル化合物として、(メタ)アクリレート類を例示すれば、下記(イ)〜(ニ)に示されるものが挙げられる。
<Polymerizable monomer component (A)>
As the polymerizable monomer component (A), known ones can be used without particular limitation. When viewed for dental use, radically polymerizable or cationically polymerizable monomers are preferable from the viewpoint of polymerization rate. Particularly preferable radically polymerizable monomers include (meth) acrylates exemplified below, which are (meth) acrylic compounds, and particularly preferable cationically polymerizable monomers include epoxies and oxetans. .. In general, as the (meth) acrylic compound preferably used, examples of (meth) acrylates include those shown in the following (a) to (d).
(イ)単官能重合性単量体
(イ−i)酸性基や水酸基を有さないもの
メチル(メタ)アクリレート、エチル(メタ)アクリレート、n−ブチル(メタ)アクリレート、2−エチルヘキシル(メタ)アクリレート、n−ラウリル(メタ)アクリレート、n−ステアリル(メタ)アクリレート、テトラフルフリル(メタ)アクリレート、グリシジル(メタ)アクリレート、メトキシエチレングリコール(メタ)アクリレート、メトキシジエチレングリコール(メタ)アクリレート、メトキシートリエチレングリコール(メタ)アクリレート、メトキシポリエチレングリコール(メタ)アクリレート、エトキシエチレングリコール(メタ)アクリレート、エトキシジエチレングリコール(メタ)アクリレート、エトキシトリエチレングリコール(メタ)アクリレート、エトキシポリエチレングリコール(メタ)アクリレート、フェノキシエチレングリコール(メタ)アクリレート、フェノキシジエチレングリコール(メタ)アクリレート、フェノキシトリエチレングリコール(メタ)アクリレート、フェノキシポリエチレングリコール(メタ)アクリレート、シクロヘキシル(メタ)アクリレート、ベンジル(メタ)アクリレート、イソボロニル(メタ)アクリレート、トリフルオロエチル(メタ)アクリレートなど。
(A) Monofunctional polymerizable monomer (i) Those having no acidic group or hydroxyl group Methyl (meth) acrylate, ethyl (meth) acrylate, n-butyl (meth) acrylate, 2-ethylhexyl (meth) Acrylate, n-lauryl (meth) acrylate, n-stearyl (meth) acrylate, tetraflufuryl (meth) acrylate, glycidyl (meth) acrylate, methoxyethylene glycol (meth) acrylate, methoxydiethylene glycol (meth) acrylate, methoxytriethylene Glycol (meth) acrylate, methoxypolyethylene glycol (meth) acrylate, ethoxyethylene glycol (meth) acrylate, ethoxydiethylene glycol (meth) acrylate, ethoxytriethylene glycol (meth) acrylate, ethoxypolyethylene glycol (meth) acrylate, phenoxyethylene glycol ( Meta) acrylate, phenoxydiethylene glycol (meth) acrylate, phenoxytriethylene glycol (meth) acrylate, phenoxypolyethylene glycol (meth) acrylate, cyclohexyl (meth) acrylate, benzyl (meth) acrylate, isobolonyl (meth) acrylate, trifluoroethyl (meth) Meta) Acrylate etc.
(イ−ii)酸性基を有するもの
(メタ)アクリル酸、N−(メタ)アクリロイルグリシン、N−(メタ)アクリロイルアスパラギン酸、N−(メタ)アクリロイル−5−アミノサリチル酸、2−(メタ)アクリロイルオキシエチルハイドロジェンサクシネート、2−(メタ)アクリロイルオキシエチルハイドロジェンフタレート、2−(メタ)アクリロイルオキシエチルハイドロジェンマレート、6−(メタ)アクリロイルオキシエチルナフタレン−1,2,6−トリカルボン酸、O−(メタ)アクリロイルチロシン、N−(メタ)アクリロイルチロシン、N−(メタ)アクリロイルフェニルアラニン、N−(メタ)アクリロイル−p−アミノ安息香酸、N−(メタ)アクリロイル−o−アミノ安息香酸、p−ビニル安息香酸、2−(メタ)アクリロイルオキシ安息香酸、3−(メタ)アクリロイルオキシ安息香酸、4−(メタ)アクリロイルオキシ安息香酸、N−(メタ)アクリロイル−5−アミノサリチル酸、N−(メタ)アクリロイル−4−アミノサリチル酸等及びこれらの化合物のカルボキシル基を酸無水物基化した化合物、11−(メタ)アクリロイルオキシウンデカン−1,1−ジカルボン酸、10−(メタ)アクリロイルオキシデカン−1,1−ジカルボン酸、12−(メタ)アクリロイルオキシドデカン−1,1−ジカルボン酸、6−(メタ)アクリロイルオキシヘキサン−1,1−ジカルボン酸、2−(メタ)アクリロイルオキシエチル−3’−メタクリロイルオキシ−2’−(3,4−ジカルボキシベンゾイルオキシ)プロピルサクシネート、4−(2−(メタ)アクリロイルオキシエチル)トリメリテートアンハイドライド、4−(2−(メタ)アクリロイルオキシエチル)トリメリテート、4−(メタ)アクリロイルオキシエチルトリメリテート、4−(メタ)アクリロイルオキシブチルトリメリテート、4−(メタ)アクリロイルオキシヘキシルトリメリテート、4−(メタ)アクリロイルオキシデシルトリメリテート、4−(メタ)アクリロイルオキシブチルトリメリテート、6−(メタ)アクリロイルオキシエチルナフタレン−1,2,6−トリカルボン酸無水物、6−(メタ)アクリロイルオキシエチルナフタレン−2,3,6−トリカルボン酸無水物、4−(メタ)アクリロイルオキシエチルカルボニルプロピオノイル−1,8−ナフタル酸無水物、4−(メタ)アクリロイルオキシエチルナフタレン−1,8−トリカルボン酸無水物、9−(メタ)アクリロイルオキシノナン−1,1−ジカルボン酸、13−(メタ)アクリロイルオキシトリデカン−1,1−ジカルボン酸、11−(メタ)アクリルアミドウンデカン−1,1−ジカルボン酸、2−(メタ)アクリロイルオキシエチルジハイドロジェンフォスフェート、2−(メタ)アクリロイルオキシエチルフェニルハイドロジェンフォスフェート、10−(メタ)アクリロイルオキシデシルジハイドロジェンフォスフェート、6−(メタ)アクリロイルオキシヘキシルジハイドロジェンフォスフェート、2−(メタ)アクリロイルオキシエチル−2−ブロモエチルハイドロジェンフォスフェート、2−(メタ)アクリルアミドエチルジハイドロジェンフォスフェート、2−(メタ)アクリルアミド−2−メチルプロパンスルホン酸、10−スルホデシル(メタ)アクリレート、3−(メタ)アクリロキシプロピル−3−ホスホノプロピオネート、3−(メタ)アクリロキシプロピルホスホノアセテート、4−(メタ)アクリロキシブチル−3−ホスホノプロピオネート、4−(メタ)アクリロキシブチルホスホノアセテート、5−(メタ)アクリロキシペンチル−3−ホスホノプロピオネート、5−(メタ)アクリロキシペンチルホスホノアセテート、6−(メタ)アクリロキシヘキシル−3−ホスホノプロピオネート、6−(メタ)アクリロキシヘキシルホスホノアセテート、10−(メタ)アクリロキシデシル−3−ホスホノプロピオネート、10−(メタ)アクリロキシデシルホスホノアセテート、2−(メタ)アクリロキシエチル−フェニルホスホネート、2−(メタ)アクリロイルオキシエチルホスホン酸、10−(メタ)アクリロイルオキシデシルホスホン酸、N−(メタ)アクリロイル−ω−アミノプロピルホスホン酸、2−(メタ)アクリロイルオキシエチルフェニルハイドロジェンホスフェート、2−(メタ)アクリロイルオキシエチル2’−ブロモエチルハイドロジェンホスフェート、2−(メタ)アクリロイルオキシエチルフェニルホスホネートなど。
(Ii) Those having an acidic group (meth) acrylic acid, N- (meth) acryloyl glycine, N- (meth) acryloyl aspartic acid, N- (meth) acryloyl-5-aminosalicylic acid, 2- (meth) Acryloyloxyethyl Hydrogen Succinate, 2- (Meta) Acryloyloxyethyl Hydrogenphthalate, 2- (Meta) Acryloyloxyethyl Hydrogenmalate, 6- (Meta) Acryloyloxyethyl Naphthalene-1,2,6-Tricarboxylic Acid , O- (meth) acryloyl tyrosine, N- (meth) acryloyl tyrosine, N- (meth) acryloylphenylalanine, N- (meth) acryloyl-p-aminobenzoic acid, N- (meth) acryloyl-o-aminobenzoic acid , P-vinyl benzoic acid, 2- (meth) acryloyloxy benzoic acid, 3- (meth) acryloyloxy benzoic acid, 4- (meth) acryloyloxy benzoic acid, N- (meth) acryloyl-5-aminosalicylic acid, N -(Meta) acryloyl-4-aminosalicylic acid and other compounds in which the carboxyl group of these compounds is acid anhydride-based, 11- (meth) acryloyloxyundecane-1,1-dicarboxylic acid, 10- (meth) acryloyloxy Decane-1,1-dicarboxylic acid, 12- (meth) acryloyl oxide Decane-1,1-dicarboxylic acid, 6- (meth) acryloyloxyhexane-1,1-dicarboxylic acid, 2- (meth) acryloyloxyethyl- 3'-methacryloyloxy-2'-(3,4-dicarboxybenzoyloxy) propylsuccinate, 4- (2- (meth) acryloyloxyethyl) trimellitate anhydride, 4- (2- (meth) acryloyl) Oxyethyl) trimerite, 4- (meth) acryloyloxyethyl trimerite, 4- (meth) acryloyloxybutyl trimerite, 4- (meth) acryloyloxyhexyl trimerite, 4- (meth) acryloyloxydecyltri Meritate, 4- (meth) acryloyloxybutyl trimerite, 6- (meth) acryloyloxyethylnaphthalene-1,2,6-tricarboxylic acid anhydride, 6- (meth) acryloyloxyethylnaphthalene-2,3 6-Tricarboxylic acid anhydride, 4- (meth) acryloyloxyethylcarbonylpropionoyl-1,8-naphthalic acid anhydride, 4- (meth) acryloyl oki Siethylnaphthalene-1,8-tricarboxylic acid anhydride, 9- (meth) acryloyloxynonane-1,1-dicarboxylic acid, 13- (meth) acryloyloxytridecane-1,1-dicarboxylic acid, 11- (meth) ) Acryloyl undecane-1,1-dicarboxylic acid, 2- (meth) acryloyloxyethyl dihydrogen phosphate, 2- (meth) acryloyloxyethylphenylhydrogen phosphate, 10- (meth) acryloyloxydecyldihydrogen Phosphate, 6- (meth) acryloyloxyhexyl dihydrogen phosphate, 2- (meth) acryloyloxyethyl-2-bromoethyl hydrogen phosphate, 2- (meth) acrylamide ethyldihydrogen phosphate, 2- (Meta) acrylamide-2-methylpropanesulfonic acid, 10-sulfodecyl (meth) acrylate, 3- (meth) acryloxypropyl-3-phosphonopropionate, 3- (meth) acryloxypropylphosphonoacetate, 4 -(Meta) acryloyloxybutyl-3-phosphonopropionate, 4- (meth) acryloyloxybutylphosphonoacetate, 5- (meth) acryloyloxypentyl-3-phosphonopropionate, 5- (meth) Acryloyloxypentylphosphonoacetate, 6- (meth) acryloylhexyl-3-phosphonopropionate, 6- (meth) acryloylhexylphosphonoacetate, 10- (meth) acryloyloxydecyl-3-phosphonopro Pionate, 10- (meth) acryloyloxydecylphosphonoacetate, 2- (meth) acryloyloxyethyl-phenylphosphonate, 2- (meth) acryloyloxyethylphosphonic acid, 10- (meth) acryloyloxydecylphosphonic acid, N -(Meta) acryloyl-ω-aminopropylphosphonic acid, 2- (meth) acryloyloxyethylphenylhydrogen phosphate, 2- (meth) acryloyloxyethyl 2'-bromoethylhydrogen phosphate, 2- (meth) acryloyloxy Ethylphenylphosphonate etc.
(イ−iii)水酸基を有するもの
2−ヒドロキシエチル(メタ)アクリレート、3−ヒドロキシプロピル(メタ)アクリレート、4−ヒドロキシブチル(メタ)アクリレート、6−ヒドロキシヘキシル(メタ)アクリレート、10−ヒドロキシデシル(メタ)アクリレート、プロピレングリコールモノ(メタ)アクリレート、グリセロールモノ(メタ)アクリレート、エリスリトールモノ(メタ)アクリレート、N−メチロール(メタ)アクリルアミド、N−ヒドロキシエチル(メタ)アクリルアミド、N、N−(ジヒドロキシエチル)(メタ)アクリルアミドなど。
(Iii) Those having a hydroxyl group 2-Hydroxyethyl (meth) acrylate, 3-hydroxypropyl (meth) acrylate, 4-hydroxybutyl (meth) acrylate, 6-hydroxyhexyl (meth) acrylate, 10-hydroxydecyl ( Meta) acrylate, propylene glycol mono (meth) acrylate, glycerol mono (meth) acrylate, erythritol mono (meth) acrylate, N-methylol (meth) acrylamide, N-hydroxyethyl (meth) acrylamide, N, N- (dihydroxyethyl) ) (Meta) acrylamide, etc.
(ロ)二官能重合性単量体
(ロ−i)芳香族化合物系のもの
2,2−ビス(メタクリロイルオキシフェニル)プロパン、2,2−ビス[(3−メタクリロイルオキシ−2−ヒドロキシプロピルオキシ)フェニル]プロパン、2,2−ビス(4−メタクリロイルオキシフェニル)プロパン、2,2−ビス(4−メタクリロイルオキシポリエトキシフェニル)プロパン、2,2−ビス(4−メタクリロイルオキシジエトキシフェニル)プロパン、2,2−ビス(4−メタクリロイルオキシテトラエトキシフェニル)プロパン、2,2−ビス(4−メタクリロイルオキシペンタエトキシフェニル)プロパン、2,2−ビス(4−メタクリロイルオキシジプロポキシフェニル)プロパン、2(4−メタクリロイルオキシジエトキシフェニル)−2(4−メタクリロイルオキシトリエトキシフェニル)プロパン、2(4−メタクリロイルオキシジプロポキシフェニル)−2−(4−メタクリロイルオキシトリエトキシフェニル)プロパン、2,2−ビス(4−メタクリロイルオキシプロポキシフェニル)プロパン、2,2−ビス(4−メタクリロイルオキシイソプロポキシフェニル)プロパン及びこれらのメタクリレートに対応するアクリレート;2−ヒドロキシエチルメタクリレート、2−ヒドロキシプロピルメタクリレート、3−クロロ−2−ヒドロキシプロピルメタクリレート等のメタクリレートあるいはこれらメタクリレートに対応するアクリレートのような−OH基を有するビニルモノマーと、ジイソシアネートメチルベンゼン、4,4‘−ジフェニルメタンジイソシアネートのような芳香族基を有するジイソシアネート化合物との付加から得られるジアダクト;ジ(メタクリルロキシエチル)ジフェニルメタンジウレタン等。
(B) Bifunctional polymerizable monomer (ro-i) Aromatic compound type 2,2-bis (methacryloyloxyphenyl) propane, 2,2-bis [(3-methacryloyloxy-2-hydroxypropyloxy) ) Phenyl] propane, 2,2-bis (4-methacryloyloxyphenyl) propane, 2,2-bis (4-methacryloyloxypolyethoxyphenyl) propane, 2,2-bis (4-methacryloyloxydiethoxyphenyl) propane , 2,2-Bis (4-methacryloyloxytetraethoxyphenyl) propane, 2,2-bis (4-methacryloyloxypentaethoxyphenyl) propane, 2,2-bis (4-methacryloyloxydipropoxyphenyl) propane, 2 (4-methacryloyloxydiethoxyphenyl) -2 (4-methacryloyloxytriethoxyphenyl) propane, 2 (4-methacryloyloxydipropoxyphenyl) -2- (4-methacryloyloxytriethoxyphenyl) propane, 2,2- Bis (4-methacryloyloxypropoxyphenyl) propane, 2,2-bis (4-methacryloyloxyisopropoxyphenyl) propane and acrylates corresponding to these methacrylates; 2-hydroxyethyl methacrylate, 2-hydroxypropyl methacrylate, 3-chloro A vinyl monomer having a -OH group such as methacrylate such as -2-hydroxypropyl methacrylate or an acrylate corresponding to these methacrylates, and a diisocyanate compound having an aromatic group such as diisocyanate methylbenzene and 4,4'-diphenylmethane diisocyanate. Diadect obtained from the addition of di (methacrylloxyethyl) diphenylmethanediurethane and the like.
(ロ−ii)脂肪族化合物系のもの
エチレングリコールジメタクリレート、ジエチレングリコールジメタクリレート、トリエチレングリコールジメタクリレート、テトラエチレングリコールジメタクリレート、ネオペンチルグリコールジメタクリレート、1,3−ブタンジオールジメタクリレート、1,4−ブタンジオールジメタクリレート、1,6−ヘキサンジオールジメタクリレート、およびこれらのメタクリレートに対応するアクリレート;1,6−ビス(メタクリルエチルオキシカルボニルアミノ)トリメチルヘキサン等の、2−ヒドロキシエチルメタクリレート、2−ヒドロキシプロピルメタクリレート、3−クロロ−2−ヒドロキシプロピルメタクリレート等のメタクリレートあるいはこれらのメタクリレートに対応するアクリレートのような−OH基を有するビニルモノマーと、ヘキサメチレンジイソシアネート、トリメチルヘキサメチレンジイソシアネート、ジイソシアネートメチルシクロヘキサン、イソフォロンジイソシアネート、メチレンビス(4−シクロヘキシルイソシアネート)のようなジイソシアネート化合物との付加体から得られるジアダクト;1,2−ビス(3−メタクリロイルオキシ−2−ヒドロキシプロポキシ)エチル等。
(Ro-iii) Aliphatic compounds Ethylene glycol dimethacrylate, diethylene glycol dimethacrylate, triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, neopentyl glycol dimethacrylate, 1,3-butanediol dimethacrylate, 1,4 -Butanediol dimethacrylate, 1,6-hexanediol dimethacrylate, and acrylates corresponding to these methacrylates; 2-hydroxyethyl methacrylate, 2-hydroxy such as 1,6-bis (methacrylethyloxycarbonylamino) trimethylhexane. Vinyl monomers having a -OH group such as methacrylates such as propyl methacrylate and 3-chloro-2-hydroxypropyl methacrylate or acrylates corresponding to these methacrylates, hexamethylene diisocyanate, trimethylhexamethylene diisocyanate, diisocyanatemethylcyclohexane, and isophorone. Diisocyanate, diastacts obtained from adducts with diisocyanate compounds such as methylenebis (4-cyclohexylisocyanate); 1,2-bis (3-methacryloyloxy-2-hydroxypropoxy) ethyl and the like.
(ハ)三官能重合性単量体
トリメチロールプロパントリメタクリレート、トリメチロールエタントリメタクリレート、ペンタエリスリトールトリメタクリレート、トリメチロールメタントリメタクリレート等のメタクリレート及びこれらのメタクリレートに対応するアクリレート等。
(C) Trifunctional polymerizable monomer Trimethylolpropane trimethacrylate, trimethylolethane trimethacrylate, pentaerythritol trimethacrylate, trimethylolmethane trimethacrylate and other methacrylates, and acrylates corresponding to these methacrylates.
(ニ)四官能重合性単量体
ペンタエリスリトールテトラメタクリレート、ペンタエリスリトールテトラアクリレート;ジイソシアネートメチルベンゼン、ジイソシアネートメチルシクロヘキサン、イソフォロンジイソシアネート、ヘキサメチレンジイソシアネート、トリメチルヘキサメチレンジイソシアネート、メチレンビス(4−シクロヘキシルイソシアネート)、4,4−ジフェニルメタンジイソシアネート、トリレン−2,4−ジイソシアネート等のジイソシアネート化合物とグリシドールジメタクリレートとの付加体から得られるジアダクト等。
(D) tetrafunctional polymerizable monomer pentaerythritol tetramethacrylate, pentaerythritol tetraacrylate; diisocyanate methylbenzene, diisocyanate methylcyclohexane, isophorone diisocyanate, hexamethylene diisocyanate, trimethylhexamethylene diisocyanate, methylenebis (4-cyclohexylisocyanate), 4 , 4-Diphenylmethane Diisocyanate, Trilene-2,4-Diisocyanate and other diisocyanates and diisducts obtained from adducts of glycidole dimethacrylate and the like.
これら多官能の(メタ)アクリレート系重合性単量体は、必要に応じて複数の種類のものを併用しても良い。さらに、必要に応じて、メチルメタクリレート、エチルメタクリレート、イソプロピルメタクリレート、ヒドロキシエチルメタクリレート、テトラヒドロフルフリルメタクリレート、グリシジルメタクリレート等のメタクリレート、及びこれらのメタクリレートに対応するアクリレート等の単官能の(メタ)アクリレート系単量体や、上記(メタ)アクリレート系単量体以外の重合性単量体を用いても良い。 A plurality of types of these polyfunctional (meth) acrylate-based polymerizable monomers may be used in combination, if necessary. Further, if necessary, methacrylates such as methyl methacrylate, ethyl methacrylate, isopropyl methacrylate, hydroxyethyl methacrylate, tetrahydrofurfuryl methacrylate, and glycidyl methacrylate, and monofunctional (meth) acrylate-based singles such as acrylates corresponding to these methacrylates. A metric or a polymerizable monomer other than the above (meth) acrylate-based monomer may be used.
本発明において、重合性単量体成分(A)としては、硬化体の物性(機械的特性や歯質に対する接着性)調整のため、一般に、複数種の重合性単量体が使用されるが、この際、成分(A)の25℃における屈折率が1.38〜1.55の範囲となるように、重合性単量体の種類及び量を設定することが望ましい。即ち、屈折率を1.38〜1.55の範囲に設定することにより、重合性単量体成分(A)から得られる重合体の屈折率nPを、おおよそ1.40〜1.57の範囲に設定でき、 nP<nFB という条件を満足させることが容易となる。なお、重合性単量体成分(A)として重合性単量体を複数種類用いる場合があるが、この場合の重合性単量体成分(A)の屈折率は、複数種の重合性単量体を混合した混合物の屈折率が上記範囲に入っていれば良く、個々の重合性単量体は必ずしも上記範囲に入っていなくてもよい。なお、重合性単量体や重合性単量体の硬化体の屈折率は、25℃にてアッベ屈折率計を用いて求めることができる。 In the present invention, as the polymerizable monomer component (A), a plurality of types of polymerizable monomers are generally used for adjusting the physical properties (mechanical properties and adhesiveness to the dentin) of the cured product. At this time, it is desirable to set the type and amount of the polymerizable monomer so that the refractive index of the component (A) at 25 ° C. is in the range of 1.38 to 1.55. That is, by setting the refractive index in the range of 1.38 to 1.55, the refractive index n P of the polymer obtained from the polymerizable monomer component (A) is approximately 1.40 to 1.57. The range can be set, and it becomes easy to satisfy the condition of n P <n FB. In addition, a plurality of types of polymerizable monomers may be used as the polymerizable monomer component (A), and the refractive index of the polymerizable monomer component (A) in this case is a plurality of types of polymerizable single amounts. The refractive index of the mixture of the bodies may be within the above range, and the individual polymerizable monomers may not necessarily be within the above range. The refractive index of the polymerizable monomer or the cured product of the polymerizable monomer can be determined at 25 ° C. using an Abbe refractive index meter.
<無機球状フィラー(B)>
歯科用硬化性組成物には、無機粉体、有機粉体等の種々の充填材が含有されているが、本発明の歯科用硬化性組成物には、干渉による着色光を発現させる目的で、平均一次粒子径が100nm以上1000nm以下の範囲内にある無機球状フィラーであって、特定の粒度分布及び特定の屈折率を有する無機球状フィラー(B)が配合される。
<Inorganic spherical filler (B)>
The dental curable composition contains various fillers such as inorganic powder and organic powder, but the dental curable composition of the present invention has the purpose of expressing colored light due to interference. An inorganic spherical filler (B) having an average primary particle size in the range of 100 nm or more and 1000 nm or less and having a specific particle size distribution and a specific refractive index is blended.
無機球状フィラー(B)が球状であり、且つ、無機球状フィラー(B)を構成する個々の粒子の数のうち90%以上が平均一次粒子径の前後の5%の範囲に存在するような狭い粒子径分布を有することにより、粒子が短距離規則性を有するように分散して、平均一次粒子径に応じた特定波長の干渉光を発生することが可能となる。ここで、無機球状フィラー(B)の平均一次粒子径は、走査型電子顕微鏡により粉体の写真を撮影し、その写真の単位視野内に観察される粒子の30個以上を選択し、それぞれの一次粒子径(最大径)を求めた平均値をいう。球状とは、略球状であればよく、必ずしも完全な真球である必要はない。走査型電子顕微鏡で粒子の写真を撮り、その単位視野内にあるそれぞれの粒子(30個以上)について最大径を測定し、その最大径に直交する方向の粒子径をその最大径で除した平均均斉度が0.6以上、より好ましくは0.8以上のものであればよい。 The inorganic spherical filler (B) is spherical, and 90% or more of the number of individual particles constituting the inorganic spherical filler (B) is narrow such that 90% or more is present in the range of 5% before and after the average primary particle size. By having the particle size distribution, the particles can be dispersed so as to have short-range regularity, and interference light having a specific wavelength corresponding to the average primary particle size can be generated. Here, for the average primary particle size of the inorganic spherical filler (B), a photograph of the powder is taken with a scanning electron microscope, and 30 or more particles observed within the unit field of view of the photograph are selected and each of them is selected. The average value obtained by determining the primary particle size (maximum size). The spherical shape may be a substantially spherical shape, and does not necessarily have to be a perfect true sphere. Take a picture of the particles with a scanning electron microscope, measure the maximum diameter of each particle (30 or more) within the unit field of view, and divide the particle diameter in the direction orthogonal to the maximum diameter by the maximum diameter. The degree of uniformity may be 0.6 or more, more preferably 0.8 or more.
無機球状フィラー(B)の個数基準粒度分布は、前記平均一次粒子径の前後の5%の範囲に存在する粒子数の全粒子数に対する割合が90%以上となるものであればよいが、上記割合は、91%以上であることが好ましく、93%以上であることがより好ましい。 The number-based particle size distribution of the inorganic spherical filler (B) may be such that the ratio of the number of particles existing in the range of 5% before and after the average primary particle size to the total number of particles is 90% or more. The ratio is preferably 91% or more, and more preferably 93% or more.
光の回折及び干渉による着色光の発現は、ブラッグ条件に則って回折及び干渉が起こり、特定波長の光が強調されることによるものであり、上記粒子径の粒子を配合すると、その歯科用硬化性組成物の硬化体には、着色光(干渉光)が発生し、その粒子径に応じた構造色が発現するようになる。 The expression of colored light due to light diffraction and interference is due to the fact that diffraction and interference occur according to Bragg conditions and light of a specific wavelength is emphasized. When particles of the above particle size are blended, the dental hardening thereof is performed. Colored light (interference light) is generated in the cured product of the sex composition, and a structural color corresponding to the particle size thereof is developed.
無機球状フィラー(B)の平均一次粒子径は、100nm以上1000nm以下の範囲内であればよい。平均一次粒子径が100nm未満である球状粒子を用いた場合、可視光の干渉現象が生じ難い。一方、平均一次粒子径が1000nmを越える無機球状フィラーを用いた場合は、光の干渉現象の発現は期待できるが、歯科充填用修復材料として用いる場合には、無機球状フィラーの沈降や研磨性の低下が生じる。 The average primary particle size of the inorganic spherical filler (B) may be in the range of 100 nm or more and 1000 nm or less. When spherical particles having an average primary particle diameter of less than 100 nm are used, the interference phenomenon of visible light is unlikely to occur. On the other hand, when an inorganic spherical filler having an average primary particle size of more than 1000 nm is used, the appearance of light interference phenomenon can be expected, but when used as a restoration material for dental filling, the inorganic spherical filler is settled and has polishability. There is a drop.
なお、本発明者らの検討により、前記無機球状フィラー(B)を用いた場合に発現する構造色の色調は、使用する無機球状フィラーの平均一次粒子径に応じ、100nm〜1000nmの範囲でその増大に伴い青色系〜黄色系〜赤色径という繰り返しサイクルで変化し、その強度は平均一次粒子径の大きいサイクルでは低下する傾向があることが判明した。したがって、強度の高い構造色を発現するという観点からは、平均一次粒子径は100nm以上500nm以下であることが好ましい。さらに黄色〜赤色の構造色を強く発現するという観点からは、平均一次粒子径は、230nm以上350nm以下、特に245nm以上300nm以下であることが好ましい。 According to the study by the present inventors, the color tone of the structural color developed when the inorganic spherical filler (B) is used is in the range of 100 nm to 1000 nm depending on the average primary particle size of the inorganic spherical filler used. It was found that the color changed in a repeating cycle of bluish-yellowish-red diameter with the increase, and the intensity tended to decrease in the cycle with a large average primary particle diameter. Therefore, from the viewpoint of developing a high-strength structural color, the average primary particle size is preferably 100 nm or more and 500 nm or less. Further, from the viewpoint of strongly expressing the structural color of yellow to red, the average primary particle size is preferably 230 nm or more and 350 nm or less, and particularly preferably 245 nm or more and 300 nm or less.
たとえば、平均一次粒子径230nm〜260nmの範囲の球状粒子を用いた場合、得られる着色光は黄色系であり、シェードガイド(「VITAClassical」、VITA社製)におけるB系(赤黄色)の範疇にある歯牙の修復に有用で、特にエナメル質から象牙質に渡って形成された窩洞の修復に有用である。平均一次粒子径260nm〜350nmの範囲の球状粒子を用いた場合、得られる着色光は赤色系であり、シェードガイド(「VITAClassical」、VITA社製)におけるA系(赤茶色)の範疇にある歯牙の修復に有用で、特にエナメル質から象牙質に渡って形成された窩洞の修復に有用である。象牙質の色相はこうした赤色系のものが多いため、上記好適な範囲の平均一次粒子径を有する無機球状フィラー(B)を使用することにより、多様な色調の修復歯牙に対して、幅広く適合性が良くすることができる。 For example, when spherical particles having an average primary particle diameter in the range of 230 nm to 260 nm are used, the obtained colored light is yellowish and falls into the category of B-based (red-yellow) in the shade guide (“VITAClasical”, manufactured by VITA). It is useful for repairing certain teeth, especially for the tooth cavity formed from enamel to dentin. When spherical particles with an average primary particle diameter in the range of 260 nm to 350 nm are used, the obtained colored light is red-based, and the teeth are in the A-based (reddish-brown) category in the shade guide (“VITAClasical”, manufactured by VITA). It is useful for repairing dentin, especially for the repair of cavities formed from enamel to dentin. Since most of the hues of dentin are reddish, by using an inorganic spherical filler (B) having an average primary particle size in the above-mentioned suitable range, it is widely compatible with restoration teeth of various color tones. Can be improved.
無機球状フィラー(B)としては、通常の歯科用硬化性組成物の成分として使用されるようなものが制限なく使用できる。具体的には、非晶質シリカ、シリカ・チタン族元素酸化物系複合酸化物粒子(シリカ・ジルコニア、シリカ・チタニアなど)、石英、アルミナ、バリウムガラス、ストロンチウムガラス、ランタンガラス、フルオロアルミノシリケートガラス、フッ化イッテルビウム、ジルコニア、チタニア、コロイダルシリカ等の無機粉体が挙げられる。このうちフィラーの屈折率の調整が容易であることから、シリカ・チタン族元素酸化物系複合酸化物粒子が好ましい。 As the inorganic spherical filler (B), those used as components of ordinary dental curable compositions can be used without limitation. Specifically, amorphous silica, silica / titanium group element oxide-based composite oxide particles (silica / zirconia, silica / titania, etc.), quartz, alumina, barium glass, strontium glass, lantern glass, fluoroaluminosilicate glass. , Inorganic powders such as itterbium fluoride, zirconia, titania, colloidal silica and the like. Of these, silica-titanium group element oxide-based composite oxide particles are preferable because the refractive index of the filler can be easily adjusted.
ここで、シリカ・チタン族元素酸化物系複合酸化物粒子とは、シリカとチタン族元素(周期律表第4族元素)酸化物との複合酸化物であり、シリカ・チタニア、シリカ・ジルコニア、シリカ・チタニア・ジルコニア等が挙げられる。このうちフィラーの屈折率を調整が可能である他、高いX線不透過性も付与できることから、シリカ・ジルコニアが好ましい。その複合比は特に制限されないが、十分なX線不透過性を付与することと、屈折率を後述する好適な範囲にする観点から、シリカの含有量が70〜95モル%であり、チタン族元素酸化物の含有量が5〜30モル%であるものが好ましい。シリカ・ジルコニアの場合、このように各複合比を変化させることにより、その屈折率を自在に変化させることができる。 Here, the silica-titanium group element oxide-based composite oxide particles are composite oxides of silica and titanium group element (group 4 element of the periodic table) oxide, and are silica titania, silica zirconia, and the like. Examples include silica, titania, and zirconia. Of these, silica zirconia is preferable because the refractive index of the filler can be adjusted and high X-ray impermeable property can be imparted. The composite ratio is not particularly limited, but from the viewpoint of imparting sufficient X-ray impermeableness and setting the refractive index within a suitable range described later, the silica content is 70 to 95 mol%, and the titanium group. Those having an element oxide content of 5 to 30 mol% are preferable. In the case of silica zirconia, the refractive index can be freely changed by changing each composite ratio in this way.
なお、これらシリカ・チタン族元素酸化物系複合酸化物粒子には、少量であれば、シリカ及びチタン族元素酸化物以外の金属酸化物の複合も許容される。具体的には、酸化ナトリウム、酸化リチウム等のアルカリ金属酸化物を10モル%以内で含有させても良い。 It should be noted that these silica-titanium group element oxide-based composite oxide particles may be composited with a metal oxide other than silica and the titanium group element oxide in a small amount. Specifically, an alkali metal oxide such as sodium oxide and lithium oxide may be contained in an amount of 10 mol% or less.
こうしたシリカ・チタン族元素酸化物系複合酸化物粒子の製造方法は特に限定されず、例えば、加水分解可能な有機ケイ素化合物と加水分解可能な有機チタン族金属化合物とを含んだ混合溶液を、アルカリ性溶媒中に添加し、加水分解を行って反応生成物を析出させる、いわゆるゾルゲル法が好適に採用される。 The method for producing such a silica-titanium group element oxide-based composite oxide particle is not particularly limited. For example, a mixed solution containing a hydrolyzable organic silicon compound and a hydrolyzable organic titanium group metal compound is alkaline. The so-called sol-gel method, in which the reaction product is precipitated by adding it to a solvent and hydrolyzing it, is preferably adopted.
これらのシリカ・チタン族酸化物系複合酸化物粒子は、シランカップリング剤により表面処理されていてもよい。シランカップリング剤による表面処理により、重合性単量体(A)の硬化体部分との界面強度に優れたものになる。代表的なシランカップリング剤としては、γ−メタクリロイルオキシアルキルトリメトキシシラン、ヘキサメチルジシラザン等の有機ケイ素化合物が挙げられる。これらシランカップリング剤の表面処理量に特に制限はなく、得られる歯科用硬化性組成物の機械的物性等を予め実験で確認したうえで最適値を決定すればよいが、好適な範囲を例示すれば、粒子100質量部に対して0.1質量部〜15質量部の範囲である。 These silica-titanium group oxide-based composite oxide particles may be surface-treated with a silane coupling agent. By surface treatment with a silane coupling agent, the interfacial strength of the polymerizable monomer (A) with the cured product portion becomes excellent. Typical silane coupling agents include organosilicon compounds such as γ-methacryloyloxyalkyltrimethoxysilane and hexamethyldisilazane. The amount of the surface treatment of these silane coupling agents is not particularly limited, and the optimum value may be determined after confirming the mechanical properties of the obtained dental curable composition in advance by experiments. If so, it is in the range of 0.1 parts by mass to 15 parts by mass with respect to 100 parts by mass of the particles.
本発明の歯科用硬化性組成物においては、干渉光を発生させる或いは構造色を発現させるために、前記無機球状フィラー(B)の25℃における屈折率:nFBは、前記重合性単量体成分(A)を重合して得られる重合体の25℃における屈折率:nPよりも大きい必要がある。すなわち、 nP<nFB の関係を満足する必要がある。nFBとnPとの差:nFB−nPは、0.001以上であるのが好ましく、0.002以上であるのがより好ましく、0.005以上であるのが最も好ましい。 In the dental curable composition of the present invention, in order to generate interference light or develop a structural color, the refractive index of the inorganic spherical filler (B) at 25 ° C.: n FB is the polymerizable monomer. The refractive index of the polymer obtained by polymerizing the component (A) at 25 ° C. must be larger than n P. That is, it is necessary to satisfy the relationship of n P <n FB. Difference between n FB and n P : n FB −n P is preferably 0.001 or more, more preferably 0.002 or more, and most preferably 0.005 or more.
本発明の歯科用硬化性組成物において、前記無機球状フィラー(B)は、そのままの形で配合されていても良いが、予め重合性単量体(A)等と混合し、重合させて得られる複合体からなる有機無機複合フィラーの形態で配合されていてもよい。 In the dental curable composition of the present invention, the inorganic spherical filler (B) may be blended as it is, but it is obtained by mixing it with a polymerizable monomer (A) or the like in advance and polymerizing it. It may be blended in the form of an organic-inorganic composite filler composed of the composite.
上記有機無機複合フィラーの製造方法は特に制限されず、例えば、無機球状フィラー(B)、重合性単量体、及び重合開始剤の各成分の所定量を混合し、加熱、光照射等の方法で重合させた後、粉砕する一般的な製造方法を採用することができる。あるいは、国際公開第2011/115007号又は国際公開第2013/039169号に記載された製造方法を採用することもできる。この製造方法では、球状無機フィラーが凝集してなる無機凝集粒子を、重合性単量体、重合開始剤、及び有機溶媒を含む重合性単量体溶媒に浸漬した後、有機溶媒を除去し、重合性単量体を加熱、光照射等の方法で重合硬化させる。国際公開第2011/115007号又は国際公開第2013/039169号に記載された製造方法によれば、無機一次粒子が凝集した無機凝集粒子の各無機一次粒子の表面を覆うとともに、各無機一次粒子を相互に結合する有機樹脂相を有し、各無機一次粒子の表面を覆う有機樹脂相の間に凝集間隙が形成されている有機無機複合フィラーが得られる。 The method for producing the organic-inorganic composite filler is not particularly limited, and for example, a method of mixing predetermined amounts of each component of the inorganic spherical filler (B), the polymerizable monomer, and the polymerization initiator, heating, light irradiation, and the like. A general production method of pulverizing after polymerizing in the above can be adopted. Alternatively, the manufacturing method described in International Publication No. 2011/115007 or International Publication No. 2013/039169 can be adopted. In this production method, inorganic agglomerated particles formed by agglomerating spherical inorganic fillers are immersed in a polymerizable monomer solvent containing a polymerizable monomer, a polymerization initiator, and an organic solvent, and then the organic solvent is removed. The polymerizable monomer is polymerized and cured by a method such as heating or light irradiation. According to the production method described in International Publication No. 2011/115007 or International Publication No. 2013/039169, the surface of each inorganic primary particle of the inorganic agglomerated particles in which the inorganic primary particles are aggregated is covered, and each inorganic primary particle is covered. An organic-inorganic composite filler having an organic resin phase bonded to each other and having a cohesive gap formed between the organic resin phases covering the surface of each inorganic primary particle can be obtained.
<不定形無機フィラー(C)>
本発明の歯科用硬化性組成物には硬化体に適切な不透明性を付与することを目的として平均粒子径が1000nmを超え3000nm未満の範囲内である不定形無機フィラーであって、特定の屈折率を有する不定形無機フィラー(C)が配合される。ここで、不定形とは、SEM等で観察される一次粒子の形状が、不規則な多数の角及び面を有している事を意味し、不定形無機フィラー(C)とは、通常は破砕や粉砕によって得られる粒子からなるフィラーを意味する。また、不定形フィラー(C)の平均粒子径は、レーザー散乱法(例えば、測定装置としてベックマン・コールター社製LS230を用い、分散媒としてエタノールを使用)にて測定された、50%粒子径(D50)を意味する。具体的には、まず、分散媒としてエタノール5ml中に測定試料を0.01〜1g加えた後、試料を懸濁した液を超音波分散器で約1〜5分間分散処理し、0.04〜2000μmの範囲の粒径の粒子の粒度分布を測定する。そして、得られた粒度分布を基にして分割された粒度範囲に対して体積をそれぞれ小径側から累積分布を描いて、累積50%となる粒径を平均粒子径(D50)とする。
<Atypical Inorganic Filler (C)>
The dental curable composition of the present invention is an amorphous inorganic filler having an average particle size in the range of more than 1000 nm and less than 3000 nm for the purpose of imparting appropriate opacity to the cured product, and is a specific refractive index. An amorphous inorganic filler (C) having a refractive index is blended. Here, the irregular shape means that the shape of the primary particles observed by SEM or the like has a large number of irregular corners and surfaces, and the amorphous inorganic filler (C) is usually referred to as an irregular shape. It means a filler composed of particles obtained by crushing or crushing. The average particle size of the amorphous filler (C) is 50% particle size (for example, LS230 manufactured by Beckman Coulter is used as a measuring device and ethanol is used as a dispersion medium) by a laser scattering method (for example, LS230 manufactured by Beckman Coulter is used as a measuring device). It means D50). Specifically, first, 0.01 to 1 g of the measurement sample was added to 5 ml of ethanol as a dispersion medium, and then the solution in which the sample was suspended was dispersed with an ultrasonic disperser for about 1 to 5 minutes, and 0.04. The particle size distribution of particles with a particle size in the range of ~ 2000 μm is measured. Then, a cumulative distribution is drawn from the small diameter side for each volume with respect to the particle size range divided based on the obtained particle size distribution, and the particle size with a cumulative total of 50% is defined as the average particle size (D50).
本発明の効果を発現するためには不定形無機フィラーとして、平均粒子径が1000nmを超え3000nm未満の範囲内であり、且つ該不定形無機フィラーの25℃における屈折率:nFCと前記重合性単量体成分(A)を重合して得られる重合体の25℃における屈折率:nPとの関係が、0.000≦nFC−nP≦0.002の関係満たす不定形無機フィラー(C)を配合する必要がある。 In order to exhibit the effect of the present invention, as an amorphous inorganic filler, the average particle size is in the range of more than 1000 nm and less than 3000 nm, and the refractive index of the amorphous inorganic filler at 25 ° C.: n FC and the polymerizable property. refractive index at 25 ° C. of the polymer obtained by polymerizing a monomer component (a): relationship between n P is, 0.000 ≦ n FC -n P ≦ 0.002 relation satisfying amorphous inorganic filler ( It is necessary to mix C).
不定形無機フィラーの平均粒子径が1000nm以下の場合には、硬化体に適切な不透明性を付与することができない。一方、3000nm以上の場合には、硬化体の不透明性が高くなりすぎるために、干渉光が発生しないか発生したとしてもそれに起因する構造色を視認することができなくなってしまう。構造色の視認性を確保しつつ、硬化体に適切な不透明性を付与できるという点で、不定形無機フィラー(C)の平均粒子径は1000nmを超え2500nm未満であることが好ましく、1000nmを超え2000nm未満であることがより好ましい。 When the average particle size of the amorphous inorganic filler is 1000 nm or less, it is not possible to impart appropriate opacity to the cured product. On the other hand, in the case of 3000 nm or more, the opacity of the cured product becomes too high, so that the structural color caused by the interference light is not generated or even if it is generated, it becomes impossible to visually recognize the structural color. The average particle size of the amorphous inorganic filler (C) is preferably more than 1000 nm and less than 2500 nm, preferably more than 1000 nm, in that it is possible to impart appropriate opacity to the cured product while ensuring the visibility of the structural color. More preferably, it is less than 2000 nm.
本発明の歯科用硬化性組成物の硬化体に付与される、「不透明性」の指標としては、厚さ1mmの硬化体の状態で測定されるコントラスト比(Yb/Yw)を用いることができる。ここでYbは、厚さ1mmの硬化体について、背景を黒色とした色差計による三刺激値測定で決定されるY刺激値を意味し、Ywは背景を白色として同様に測定したときのY刺激値を意味する。コントラスト比(Yb/Yw)が0.3未満の場合には、たとえばIII級窩洞やIV級窩洞の修復に用いた場合の修復部位(充填部位)における硬化体の明度(色の濃淡)が低くなり、当該部位における透過光が強く、硬化体からの着色光が弱くなるため、良好な色調適合性が得られ難い。また、前記コントラスト比が0.7を超える場合には、硬化体の明度が高くなり、修復部位(充填部位)表面での反射光が強く、硬化体からの着色光が弱くなり、やはり良好な色調適合性を得ることができ難くなる。したがって、コントラスト比(Yb/Yw)が0.30以上0.70以下の範囲であるときには、前記した「適切な不透明性」であるといえる。III級窩洞やIV級窩洞の修復において、優れた色調適合性を有するためには、前記コントラスト比(Yb/Yw)は0.35以上0.65以下の範囲であるのが好ましく、0.40以上0.60以下の範囲であるのがより好ましい。 As an index of "opacity" given to the cured product of the dental curable composition of the present invention, the contrast ratio (Y b / Y w ) measured in the state of the cured product having a thickness of 1 mm is used. Can be done. Here, Y b means a Y stimulus value determined by tristimulus value measurement with a color difference meter with a black background for a cured product having a thickness of 1 mm, and Y w means a Y stimulus value when the background is white and similarly measured. It means the Y stimulation value. When the contrast ratio (Y b / Y w ) is less than 0.3, the brightness (shade of color) of the cured product at the repair site (filling site) when used for repairing a class III or IV cavity, for example. Is low, the transmitted light at the site is strong, and the colored light from the cured product is weakened, so that it is difficult to obtain good color tone compatibility. Further, when the contrast ratio exceeds 0.7, the brightness of the cured product is high, the reflected light on the surface of the repaired portion (filled portion) is strong, and the colored light from the cured product is weakened, which is also good. It becomes difficult to obtain color tone compatibility. Therefore, when the contrast ratio (Y b / Y w ) is in the range of 0.30 or more and 0.70 or less, it can be said that the above-mentioned "appropriate opacity" is obtained. In order to have excellent color compatibility in the repair of class III and IV cavities, the contrast ratio (Y b / Y w ) is preferably in the range of 0.35 or more and 0.65 or less, and is 0. More preferably, it is in the range of .40 or more and 0.60 or less.
また、本発明の歯科用硬化性組成物の硬化体では、不定形無機フィラー(C)を添加することによって不透明性が増大するものの、構造色の視認性は保たれる。すなわち、前記硬化体で発生する干渉光又は当該硬化体で発現する構造色は、厚さ1mmの硬化体について色差計を用いて測定した、黒背景下での分光反射率曲線で確認することができる。前記したように、構造色としては無機球状フィラー(B)の平均一次粒子径の大きさに応じた色調(通常、青色系〜黄色系〜赤色系といった広い色調範囲の中から目的に応じて選ばれる好ましい色調)の構造色が発現し、黒背景下での色差計を用いた反射射率測定では、当該色調に対応する波長領域の反射が有意に高くなる。 Further, in the cured product of the dental curable composition of the present invention, although the opacity is increased by adding the amorphous inorganic filler (C), the visibility of the structural color is maintained. That is, the interference light generated in the cured product or the structural color developed in the cured product can be confirmed by the spectral reflectance curve under a black background measured with a color difference meter for the cured product having a thickness of 1 mm. it can. As described above, the structural color is selected according to the purpose from a wide color tone range (usually, bluish to yellow to red) according to the size of the average primary particle size of the inorganic spherical filler (B). The structural color of the desired color tone) is developed, and in the reflection reflectance measurement using a color difference meter under a black background, the reflection in the wavelength region corresponding to the color tone is significantly increased.
本発明の歯科用硬化性組成物をたとえばIII級窩洞やIV級窩洞の修復に用いた場合には、硬化体が前記したような適切な不透明性を有することに加えて黄色〜赤色に確認可能(視認可能な)な構造色を発現することが、色調適合性の高い審美修復を行う上で好ましい。このような観点から、本発明の歯科用硬化性組成物は分光反射率比:SR1/SR2が0.8以上2.0以下の範囲となる硬化体を与えるものであることが好ましい。ここで、上記SR1及びSR2とは、本発明の歯科用硬化性組成物を硬化させて得られる厚さ1mmの硬化体について色差計を用いて測定した、黒背景下での分光反射率曲線において、600nm以上750nm以下の波長領域(黄色〜赤色域)内における分光反射率の最大値(SR1)及び400nm以上500nm以下の波長領域(青色域)内における分光反射率の最大値(SR2)を意味する。前記分光反射率比が0.8未満の場合には、黄〜赤色の着色光が弱く、黄色味もしくは赤味を帯びた天然歯牙への色調適合性が得られ難くなる傾向がある。また、前記分光反射率比が2.0を超えた場合には黄〜赤色の着色光が強すぎるため、やはり良好な色調適合性が得られ難くなる。III級窩洞やIV級窩洞の修復に用いたときに優れた色調適合性を有するためには、前記分光反射率比は、0.9以上1.5以下の範囲であることが、より好ましい。 When the dental curable composition of the present invention is used for repairing, for example, a class III or IV cavity, the cured product can be confirmed to be yellow to red in addition to having appropriate opacity as described above. It is preferable to develop a (visible) structural color in order to perform aesthetic restoration with high color tone compatibility. From this point of view, it is preferable that the dental curable composition of the present invention provides a cured product having a spectral reflectance ratio: SR 1 / SR 2 in the range of 0.8 or more and 2.0 or less. Here, SR 1 and SR 2 are spectral reflectances under a black background measured by using a color difference meter for a cured product having a thickness of 1 mm obtained by curing the dental curable composition of the present invention. In the curve, the maximum value of spectral reflectance (SR 1 ) in the wavelength region of 600 nm or more and 750 nm or less (yellow to red region) and the maximum value of spectral reflectance in the wavelength region of 400 nm or more and 500 nm or less (blue region) (SR). 2 ) means. When the spectral reflectance ratio is less than 0.8, the yellow to red colored light is weak, and it tends to be difficult to obtain color tone compatibility with yellowish or reddish natural teeth. Further, when the spectral reflectance ratio exceeds 2.0, the yellow to red colored light is too strong, so that it is difficult to obtain good color tone compatibility. In order to have excellent color compatibility when used for repairing a class III or IV cavity, the spectral reflectance ratio is more preferably in the range of 0.9 or more and 1.5 or less.
上記不定形無機フィラー(C)の材質は特に制限されず、公知のものが使用可能である。具体的には、ホウケイ酸ガラス、ソーダガラス、重金属(例えばバリウム、ストロンチウム、ジルコニウム)を含むガラス、アルミノシリケートガラス、フルオロアルミノシリケートガラス、ガラスセラミックス、フッ化イッテルビウム、フッ化イットリウム等の金属フッ化物、シリカや、シリカ・ジルコニア、シリカ・チタニア、シリカ・アルミナ等の複合無機酸化物等が好適である。特に好適な例としては、X線造影性を有し、より耐磨耗性に優れた硬化体が得られることから、シリカとジルコニアを主成分とする複合酸化物が挙げられる。 The material of the amorphous inorganic filler (C) is not particularly limited, and known materials can be used. Specifically, borosilicate glass, soda glass, glass containing heavy metals (for example, barium, strontium, zirconium), aluminosilicate glass, fluoroaluminosilicate glass, glass ceramics, itterbium fluoride, yttrium fluoride and other metal fluorides, Suitable are silica, composite inorganic oxides such as silica-zirconia, silica-titania, and silica-alumina. A particularly preferable example is a composite oxide containing silica and zirconia as main components because a cured product having X-ray contrast property and more excellent wear resistance can be obtained.
上記不定形無機フィラー(C)は、マトリックスとしての重合性単量体への分散性を改善する目的でその表面を適当な表面処理剤で処理してから用いることが好ましい。該処理の方法としては、略球状無機フィラーの表面処理方法として前記した方法同様、何ら制限無く使用可能である。 The amorphous inorganic filler (C) is preferably used after its surface is treated with an appropriate surface treatment agent for the purpose of improving the dispersibility in the polymerizable monomer as a matrix. As the method of the treatment, the surface treatment method of the substantially spherical inorganic filler can be used without any limitation as in the above-mentioned method.
本発明における無機球状フィラー(B)及び不定形無機フィラー(C)の合計の配合量は、重合性単量体(A)100質量部に対して、100質量部以上1500質量部以下、特に100質量部以上1000質量部以下であることが好ましい。構造色が良好に発現するという観点から、不定形無機フィラー(C)の配合量の割合は無機球状フィラー(B)および不定形無機フィラー(C)の合計配合量の5%以上30%以下となるように配合することが好ましい。このような配合量及び配合割合であればIII級窩洞やIV級窩洞の修復に対して自然な色調を呈し、より審美的な修復が可能となる。 The total amount of the inorganic spherical filler (B) and the amorphous inorganic filler (C) in the present invention is 100 parts by mass or more and 1500 parts by mass or less, particularly 100 parts by mass with respect to 100 parts by mass of the polymerizable monomer (A). It is preferably parts by mass or more and 1000 parts by mass or less. From the viewpoint of good structural color expression, the proportion of the amorphous inorganic filler (C) is 5% or more and 30% or less of the total amount of the inorganic spherical filler (B) and the amorphous inorganic filler (C). It is preferable to mix them in such a manner. With such a blending amount and blending ratio, a natural color tone is exhibited with respect to the repair of the III-class or IV-class cavity, and more aesthetic repair is possible.
<重合開始剤(D)>
重合開始剤(D)は前記重合性単量体(A)を重合させる機能を有するものであれば特に限定されないが、口腔内で硬化させる場合が多い歯科の直接充填修復用途で使用される光重合開始剤又は化学重合開始剤を使用することが好ましく、混合操作の必要が無く簡便な点から、光重合開始剤(組成)を使用することが更に好ましい。
<Polymerization initiator (D)>
The polymerization initiator (D) is not particularly limited as long as it has a function of polymerizing the polymerizable monomer (A), but is used for direct filling and restoration of dentistry, which is often cured in the oral cavity. It is preferable to use a polymerization initiator or a chemical polymerization initiator, and it is more preferable to use a photopolymerization initiator (composition) from the viewpoint of simplicity without the need for a mixing operation.
光重合に用いる重合開始剤としては、ベンゾインメチルエーテル、ベンゾインエチルエーテル、ベンゾインイソプロピルエーテルなどのベンゾインアルキルエーテル類、ベンジルジメチルケタール、ベンジルジエチルケタールなどのベンジルケタール類、ベンゾフェノン、4,4'−ジメチルベンゾフェノン、4−メタクリロキシベンゾフェノンなどのベンゾフェノン類、ジアセチル、2,3−ペンタジオンベンジル、カンファーキノン、9,10−フェナントラキノン、9,10−アントラキノンなどのα−ジケトン類、2,4−ジエトキシチオキサンソン、2−クロロチオキサンソン、メチルチオキサンソン等のチオキサンソン化合物、ビス−(2,6−ジクロロベンゾイル)フェニルホスフィンオキサイド、ビス−(2,6−ジクロロベンゾイル)−2,5−ジメチルフェニルホスフィンオキサイド、ビス−(2,6−ジクロロベンゾイル)−4−プロピルフェニルホスフィンオキサイド、ビス−(2,6−ジクロロベンゾイル)−1−ナフチルホスフィンオキサイド、ビス(2,4,6−トリメチルベンゾイル)―フェニルホスフィンオキサイドなどのビスアシルホスフィンオキサイド類等が使用できる。 Examples of the polymerization initiator used for photopolymerization include benzoin alkyl ethers such as benzoin methyl ether, benzoin ethyl ether and benzoin isopropyl ether, benzyl ketals such as benzyl dimethyl ketal and benzyl diethyl ketal, benzophenone and 4,4'-dimethylbenzophenone. , Benzoyl compounds such as 4-methacryloxybenzophenone, diacetyl, 2,3-pentadionebenzyl, camphorquinone, 9,10-phenanthraquinone, α-diketones such as 9,10-anthraquinone, 2,4-di Thioxanson compounds such as ethoxythioxanthone, 2-chlorothioxanthone, methylthioxanthone, bis- (2,6-dichlorobenzoyl) phenylphosphine oxide, bis- (2,6-dichlorobenzoyl) -2,5-dimethyl Phenylphosphine oxide, bis- (2,6-dichlorobenzoyl) -4-propylphenylphosphine oxide, bis- (2,6-dichlorobenzoyl) -1-naphthylphosphine oxide, bis (2,4,6-trimethylbenzoyl) -Bisacylphosphine oxides such as phenylphosphine oxide can be used.
なお、光重合開始剤には、しばしば還元剤が添加されるが、その例としては、2−(ジメチルアミノ)エチルメタクリレート、4−ジメチルアミノ安息香酸エチル、N−メチルジエタノールアミンなどの第3級アミン類、ラウリルアルデヒド、ジメチルアミノベンズアルデヒド、テレフタルアルデヒドなどのアルデヒド類、2−メルカプトベンゾオキサゾール、1−デカンチオール、チオサルチル酸、チオ安息香酸などの含イオウ化合物などを挙げることができる。 A reducing agent is often added to the photopolymerization initiator, and examples thereof include tertiary amines such as 2- (dimethylamino) ethyl methacrylate, ethyl 4-dimethylaminobenzoate, and N-methyldiethanolamine. Examples include aldehydes such as lauryl aldehyde, dimethylaminobenzaldehyde and terephthalaldehyde, and sulfur-containing compounds such as 2-mercaptobenzoxazole, 1-decanthyl, thiosartyl acid and thiobenzoic acid.
更に、上記光重合開始剤、還元性化合物に加えて光酸発生剤を加えて用いる例がしばしば見られる。このような光酸発生剤としては、ジアリールヨードニウム塩系化合物、スルホニウム塩系化合物、スルホン酸エステル化合物、およびハロメチル置換−S−トリアジン誘導体、ピリジニウム塩系化合物等が挙げられる。 Further, there are often examples of using a photoacid generator in addition to the above photopolymerization initiator and reducing compound. Examples of such a photoacid generator include diaryliodonium salt compounds, sulfonium salt compounds, sulfonic acid ester compounds, halomethyl-substituted-S-triazine derivatives, pyridinium salt compounds and the like.
これら重合開始剤は単独で用いることもあるが、2種以上を混合して使用してもよい。重合開始剤の配合量は目的に応じて有効量を選択すればよいが、重合性単量体100質量部に対して通常0.01〜10質量部の割合であり、より好ましくは0.1〜5質量部の割合で使用される。 These polymerization initiators may be used alone, but two or more of them may be mixed and used. The amount of the polymerization initiator to be blended may be selected as an effective amount according to the purpose, but is usually 0.01 to 10 parts by mass, more preferably 0.1, based on 100 parts by mass of the polymerizable monomer. It is used in a proportion of ~ 5 parts by mass.
<その他の添加剤>
本発明の歯科用複合修復材料には、その効果を阻害しない範囲で、上記(A)〜(D)成分の他、公知の他の添加剤を配合することができる。具体的には、重合禁止剤、紫外線吸収剤等が挙げられる。また、粘度調整等を目的として、光の波長より十分に小さく色調や透明性に影響を与え難い粒径のフィラーを配合することができる。
<Other additives>
In addition to the above components (A) to (D), other known additives can be added to the dental composite restoration material of the present invention as long as the effect is not impaired. Specific examples thereof include a polymerization inhibitor and an ultraviolet absorber. Further, for the purpose of adjusting the viscosity or the like, a filler having a particle size that is sufficiently smaller than the wavelength of light and does not easily affect the color tone and transparency can be blended.
本願発明では前述したとおり、顔料などの着色物質を用いなくても、天然歯牙との色調適合性が良好な修復が単一のペースト(歯科用硬化性組成物)で可能になる。したがって、時間と共に変色する虞のある顔料は配合しない態様が好ましい。ただし、本願発明においては、顔料の配合自体を否定するものではなく、無機球状フィラーの干渉による着色光の妨げにならない程度の顔料は配合しても構わない。具体的には、重合性単量体100質量部に対して0.0005〜0.5質量部程度、好ましくは0.001〜0.3質量部程度の顔料であれば配合しても構わない。 In the present invention, as described above, restoration with good color compatibility with natural teeth can be performed with a single paste (dental curable composition) without using a coloring substance such as a pigment. Therefore, it is preferable not to blend a pigment that may change color with time. However, in the present invention, the blending of the pigment itself is not denied, and a pigment that does not interfere with the colored light due to the interference of the inorganic spherical filler may be blended. Specifically, any pigment of about 0.0005 to 0.5 parts by mass, preferably about 0.001 to 0.3 parts by mass with respect to 100 parts by mass of the polymerizable monomer may be blended. ..
本発明の歯科用硬化性組成物は、所定量の前記成分(A)乃至(D)を量りとり、混合することにより調製することができる。このとき、無機球状フィラー(B)及び不定形無機フィラー(C)が重合性単量体(A)に分散する条件で混合することが好ましい。また、発現する構造色の視認性が低下させずに本発明の効果である良好な色調適合性が得られ易いという観点から、本発明の歯科用硬化性組成物は減圧条件下で脱泡することで、1000nm以上の気泡が実質的に含まれないように調製することが好ましい。 The dental curable composition of the present invention can be prepared by weighing and mixing a predetermined amount of the above components (A) to (D). At this time, it is preferable to mix the inorganic spherical filler (B) and the amorphous inorganic filler (C) under the condition that they are dispersed in the polymerizable monomer (A). In addition, the dental curable composition of the present invention defoams under reduced pressure conditions from the viewpoint that good color tone compatibility, which is the effect of the present invention, can be easily obtained without deteriorating the visibility of the developed structural color. Therefore, it is preferable to prepare so that bubbles of 1000 nm or more are not substantially contained.
本発明の歯科用硬化性組成物は上記のような光硬化性コンポジットレジンに代表される歯科用充填修復材料として特に好適に使用されるが、それに限定されるものではなく、その他の用途にも好適に使用できる。その用途としては、例えば歯科用セメント、支台築造用の修復材料等が挙げられる。 The dental curable composition of the present invention is particularly preferably used as a dental filling restoration material typified by a photocurable composite resin as described above, but is not limited thereto, and may be used for other purposes as well. Can be preferably used. Examples of its use include dental cement, restoration materials for abutment construction, and the like.
以下、実施例によって本発明をさらに具体的に説明するが、本発明はこれらの実施例に制限されるものではない。 Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited to these Examples.
先ず、実施例及比較例における各種物性測定方法について説明する。
(1)無機球状フィラーの平均粒子径
走査型電子顕微鏡(フィリップス社製、「XL−30S」)で粉体の写真を撮り、その写真の単位視野内に観察される粒子の数(30個以上)及び一次粒子径(最大径)を測定し、測定値に基づき下記式により平均粒子径を算出した。
First, various physical property measurement methods in Examples and Comparative Examples will be described.
(1) Average particle size of inorganic spherical filler A scanning electron microscope (“XL-30S” manufactured by Philips) takes a picture of the powder, and the number of particles observed in the unit field of view of the picture (30 or more). ) And the primary particle size (maximum size) were measured, and the average particle size was calculated by the following formula based on the measured values.
(2)無機球状フィラー(B)における、平均一次粒子径の前後の5%の範囲に存在する粒子の割合
先ず、前記した写真の単位視野内に観察される個々の粒子(30個以上)について、その一次粒子径を測定すると共に、一次粒子径が前記(1)で求めた平均一次粒子径の95%未満となる粒子の数と、一次粒子径が前記平均一次粒子径の105%を越える粒子の数を計測し、その合計個数を求めた。次いで、写真の単位視野内に観察される全粒子数(30個以上)から前記合計個数を差し引くことにより個数基準粒度分布において前記平均一次粒子径の前後の5%の範囲に存在する粒子数を求め、最後に当該粒子数の全粒子数に占める割合(%)を求め、平均一次粒子径の前後の5%の範囲に存在する粒子の割合(%)とした。
(2) Percentage of particles present in the range of 5% before and after the average primary particle size in the inorganic spherical filler (B) First, regarding individual particles (30 or more) observed in the unit field of view of the above-mentioned photograph. , The number of particles whose primary particle size is less than 95% of the average primary particle size obtained in (1) above, and the primary particle size exceeds 105% of the average primary particle size. The number of particles was measured and the total number was calculated. Next, by subtracting the total number of particles from the total number of particles (30 or more) observed in the unit field of view of the photograph, the number of particles existing in the range of 5% before and after the average primary particle size in the number-based particle size distribution is determined. Finally, the ratio (%) of the number of the particles to the total number of particles was determined, and the ratio (%) of the particles existing in the range of 5% before and after the average primary particle size was used.
(3)均斉度
走査型電子顕微鏡(フィリップス社製、「XL−30S」)で粉体の写真を撮り、その写真の単位視野内にある個々の粒子(30個以上)について、その最大径に直交する方向の粒子径をその最大径で除した値の平均を均斉度とした。
(3) Uniformity Take a picture of the powder with a scanning electron microscope (“XL-30S” manufactured by Philips), and set the maximum diameter of each particle (30 or more) within the unit field of view of the picture. The average of the values obtained by dividing the particle diameters in the orthogonal directions by the maximum diameter was defined as the uniformity.
(4)屈折率の測定
<重合性単量体成分(A)の屈折率>
用いた重合性単量体(或いは重合性単量体の混合物)の屈折率は、アッベ屈折率計(アタゴ社製)を用いて25℃の恒温室にて測定した。
<重合性単量体成分(A)の重合体の屈折率nP>
用いた重合性単量体成分(重合性単量体或いは重合性単量体の混合物)を、窩洞内での重合条件とほぼ同じ条件で重合して得た重合体試料について、アッベ屈折率計(アタゴ社製)を用いて25℃の恒温室にて測定して屈折率nPを決定した。
即ち、重合性単量体成分(A)に当該成分の質量を基準としてCQ 0.3質量%、DMBE 1.0質量%、HQME 0.15質量%を混合して得た均一な組成物を、φ7mm×0.5mmの孔を有する型に入れ、両面にポリエステルフィルムを圧接した。その後、光量500mW/cm2のハロゲン型歯科用光照射器(Demetron LC、サイブロン社製)を用いて30秒間光照射し硬化させた後、型から取り出して、重合体試料を作製した。なお、屈折率測定に際しては、試料を装置にセットする時に、重合体と測定面を密着させる目的でブロモナフタレン(試料を溶解せず、かつ試料よりも屈折率の高い溶媒)を試料に滴下した。
<無機球状フィラーの屈折率をnFB及び不定形無機フィラーの屈折率>
用いた無機球状フィラー及び不定形無機フィラーの屈折率は、アッベ屈折率計(アタゴ社製)を用いて液浸法によって測定した。
即ち、25℃の恒温室において、100mlサンプルビン中、無機球状フィラー若しくはその表面処理物1gを無水トルエン50ml中に分散させる。この分散液をスターラーで攪拌しながら1−ブロモトルエンを少しずつ滴下し、分散液が最も透明になった時点の分散液の屈折率を測定し、得られた値を無機球状フィラー及び不定形無機フィラーの屈折率とした。
(4) Measurement of refractive index <Refractive index of polymerizable monomer component (A)>
The refractive index of the polymerizable monomer (or a mixture of the polymerizable monomers) used was measured in a constant temperature room at 25 ° C. using an Abbe refractive index meter (manufactured by Atago Co., Ltd.).
<Refractive index n P of the polymer of the polymerizable monomer component (A)>
An Abbe Refractive Index Meter was obtained from a polymer sample obtained by polymerizing the polymerizable monomer component (polymerizable monomer or a mixture of polymerizable monomers) used under substantially the same conditions as the polymerization conditions in the cavity. The refractive index n P was determined by measuring in a constant temperature room at 25 ° C. using (manufactured by Atago).
That is, a uniform composition obtained by mixing the polymerizable monomer component (A) with CQ 0.3% by mass, DMBE 1.0% by mass, and HQME 0.15% by mass based on the mass of the component is obtained. , A mold having a hole of φ7 mm × 0.5 mm was placed, and polyester films were pressure-welded on both sides. Then, it was cured by irradiating it with light for 30 seconds using a halogen type dental light irradiator (Demetron LC, manufactured by Cybron) having a light intensity of 500 mW / cm 2, and then it was taken out from the mold to prepare a polymer sample. In the refractive index measurement, when the sample was set in the device, bromonaphthalene (a solvent that does not dissolve the sample and has a higher refractive index than the sample) was added dropwise to the sample for the purpose of bringing the polymer into close contact with the measurement surface. ..
<Refractive index of inorganic spherical filler n FB and refractive index of amorphous inorganic filler>
The refractive index of the inorganic spherical filler and the amorphous inorganic filler used was measured by an immersion method using an Abbe refractive index meter (manufactured by Atago Co., Ltd.).
That is, in a constant temperature room at 25 ° C., 1 g of an inorganic spherical filler or a surface-treated product thereof is dispersed in 50 ml of anhydrous toluene in a 100 ml sample bottle. While stirring this dispersion with a stirrer, 1-bromotoluene is added dropwise little by little, the refractive index of the dispersion at the time when the dispersion becomes the most transparent is measured, and the obtained values are used as an inorganic spherical filler and an amorphous inorganic. The refractive index of the filler was used.
(5)硬化性組成物のコントラスト比(Yb/Yw)の評価
実施例及び比較例で調製された硬化性組成物のペーストを7mmφ×1mmの貫通した孔を有する型にいれ、両面にポリエステルフィルムを圧接した。可視光線照射器(トクヤマ製、パワーライト)で両面を30秒ずつ光照射し硬化させた後、型から取り出して、色差計(東京電色製、「TC−1800MKII」)を用いて、上記硬化体の三刺激値のY値(背景色黒及び白)を測定した。得られた背景色黒のY値(Yb)及び背景色白のY値(Yw)に基づいてコントラスト比(Yb/Yw)を計算した。
(5) Evaluation of Contrast Ratio (Y b / Y w ) of Curable Composition Put the paste of the curable composition prepared in Examples and Comparative Examples into a mold having a through hole of 7 mmφ × 1 mm, and put it on both sides. The polyester film was pressure welded. After irradiating both sides with a visible light irradiator (manufactured by Tokuyama, power light) for 30 seconds each to cure, remove from the mold and use a color difference meter (manufactured by Tokyo Denshoku, "TC-1800MKII") to cure the above. The Y value (background color black and white) of the tristimulus values of the body was measured. The contrast ratio (Y b / Y w ) was calculated based on the Y value (Y b ) of the obtained background color black and the Y value (Y w) of the background color white.
(6)目視による着色光(干渉光)の評価
実施例及び比較例で調製された歯科用硬化性組成物のペーストを7mmφ×1mmの孔を有する型にいれ、両面はポリエステルフィルムで圧接した。可視光線照射器(トクヤマ製、パワーライト)で両面を30秒ずつ光照射し硬化させた後、型から取り出して、10mm角程度の黒いテープ(カーボンテープ)の粘着面に載せ、目視にて着色光の色調を確認した。
(6) Visual Evaluation of Colored Light (Interference Light) The paste of the dental curable composition prepared in Examples and Comparative Examples was placed in a mold having a hole of 7 mmφ × 1 mm, and both sides were pressure-welded with a polyester film. After irradiating both sides with a visible light irradiator (manufactured by Tokuyama, power light) for 30 seconds each to cure, take it out of the mold, place it on the adhesive surface of black tape (carbon tape) of about 10 mm square, and visually color it. I checked the color tone of the light.
(7)分光反射率比(黒背景におけるSR1/SR2)
実施例及び比較例で調製された硬化性組成物のペーストを7mmφ×1mmの貫通した孔を有する型にいれ、両面にポリエステルフィルムを圧接した。可視光線照射器(トクヤマ製、パワーライト)で両面を30秒ずつ光照射し硬化させた後、型から取り出して、色差計(東京電色製、「TC−1800MKII」)を用いて、黒背景下で分光反射率を測定し、黄〜赤色域(600−750nm)の反射率の最大値:SR1及び青色域(400−500nm)の反射率の最大値:SR2を求め、SR1をSR2で除することで分光反射率比を算出した。
(7) Spectral reflectance ratio (SR 1 / SR 2 on a black background)
The paste of the curable composition prepared in Examples and Comparative Examples was placed in a mold having a through hole of 7 mmφ × 1 mm, and polyester films were pressure-welded on both sides. After irradiating both sides with a visible light irradiator (manufactured by Tokuyama, power light) for 30 seconds each to cure, remove from the mold and use a color difference meter (manufactured by Tokyo Denshoku, "TC-1800MKII") to black background. The spectral reflectance is measured below, and the maximum reflectance in the yellow to red region (600-750 nm): SR 1 and the maximum reflectance in the blue region (400-500 nm): SR 2 are obtained, and SR 1 is obtained. The spectral reflectance ratio was calculated by dividing by SR 2.
(8)白背景の分光反射率による着色光(干渉光)の評価
実施例及び比較例で調製された硬化性組成物のペーストを7mmφ×1mmの貫通した孔を有する型にいれ、両面にポリエステルフィルムを圧接した。可視光線照射器(トクヤマ製、パワーライト)で両面を30秒ずつ光照射し硬化させた後、型から取り出して、色差計(東京電色製、「TC−1800MKII」)を用いて、白背景下で分光反射率を測定した。
(8) Evaluation of Colored Light (Interference Light) by Spectral Reflectance on a White Background The paste of the curable composition prepared in Examples and Comparative Examples was placed in a mold having a through hole of 7 mmφ × 1 mm, and polyester was placed on both sides. The film was pressed. After irradiating both sides with a visible light irradiator (manufactured by Tokuyama, power light) for 30 seconds each to cure, remove from the mold and use a color difference meter (manufactured by Tokyo Denshoku, "TC-1800MKII") to create a white background. The spectral reflectance was measured below.
(9)曲げ強さ
歯科用硬化性組成物のペーストについて、充填器を用いてステンレス製型枠に充填し、ポリプロピレンで圧接した状態で、可視光線照射器パワーライト(トクヤマ社製)を用いて一方の面から30秒×3回、全体に光が当たるように場所を変えてポリプロピレンに密着させて光照射を行なった。次いで、反対の面からも同様にポリプロピレンに密着させて30秒×3回光照射を行い、硬化体を得た。#1500の耐水研磨紙にて、硬化体を2×2×25mmの角柱状に整え、試料片とした。得られた試験片を試験機(島津製作所製、オートグラフAG5000D)に装着し、支点間距離20mm、クロスヘッドスピード1mm/分で3点曲げ破壊強度を測定し、荷重−たわみ曲線を得、以下に示す式により、曲げ強度:σB(Pa)及び曲げ弾性率:EB(Pa)を求めた。なお、試験片5個について評価し、その平均値を曲げ強さとした。
(9) Flexural strength The paste of the dental curable composition was filled in a stainless steel mold using a filler, pressed with polypropylene, and then used with a visible light irradiator Power Light (manufactured by Tokuyama Corporation). Light irradiation was performed for 30 seconds x 3 times from one surface in close contact with polypropylene at different locations so that the entire surface was exposed to light. Next, the opposite surface was similarly brought into close contact with polypropylene and irradiated with light for 30 seconds × 3 times to obtain a cured product. The cured product was prepared into a 2 × 2 × 25 mm prismatic shape with # 1500 water-resistant abrasive paper to prepare a sample piece. The obtained test piece was mounted on a testing machine (manufactured by Shimadzu Corporation, Autograph AG5000D), and the bending fracture strength at three points was measured at a distance between fulcrums of 20 mm and a crosshead speed of 1 mm / min to obtain a load-deflection curve. It is shown by the equation, bending strength: sigma B (Pa) and flexural modulus: was determined E B (Pa). Five test pieces were evaluated, and the average value was taken as the bending strength.
但し、前記式中の各記号の意味及び単位は以下に示すとおりである。
P:試験片破折時の荷重(N)
S:支点間距離(m)
W:試験片の幅(m)
B:試験片の厚さ(m)
F/Y:荷重−たわみ曲線の直線部分の勾配(N/m)。
However, the meaning and unit of each symbol in the above formula are as shown below.
P: Load at the time of breaking the test piece (N)
S: Distance between fulcrums (m)
W: Width of test piece (m)
B: Specimen thickness (m)
F / Y: Gradient (N / m) of the straight part of the load-deflection curve.
(10)色調適合性の評価
右上1番のIV級窩洞(幅3mm、高さ3mm)を再現した歯牙修復用模型歯を用いて、欠損部に硬化性ペーストを充填し硬化、研磨し、色調適合性を目視にて確認した。なお、歯牙修復用模型歯としては、シェードガイド「VITAPAN Classical」におけるA系(赤茶色)の範疇の中にあって、高色相且つ高彩度の高色度模型歯(A4相当)と低色相且つ低彩度の低色度模型歯(A1相当)及び、シェードガイド「VITAPAN Classical」におけるB系(赤黄色)の範疇の中にあって、高色相且つ高彩度の高色度模型歯(B4相当)と低色相且つ低彩度の低色度模型歯(B1相当)を用いた。
◎:修復物の色調が歯牙修復用模型歯と良く適合している。
○:修復物の色調が歯牙修復用模型歯と類似している。
△:修復物の色調が歯牙修復用模型歯と類似しているが適合性は良好でない。
×:修復物の色調が歯牙修復用模型歯と適合していない。
(10) Evaluation of color tone compatibility Using a model tooth for tooth restoration that reproduces the No. 1 IV-class tooth cavity (width 3 mm, height 3 mm) on the upper right, fill the defect with a curable paste, cure, polish, and color tone. The compatibility was visually confirmed. The model teeth for tooth restoration are in the category of A system (reddish brown) in the shade guide "VITAPAN Classical", and have high hue and high saturation high hue model teeth (equivalent to A4) and low hue and low hue. Low-saturation model teeth (equivalent to A1) and high-hue and high-saturation high-saturation model teeth (equivalent to B4) in the category of B system (red-yellow) in the shade guide "VITAPAN Classical". Low hue and low saturation model teeth (equivalent to B1) were used.
⊚: The color tone of the restoration matches well with the model tooth for tooth restoration.
◯: The color tone of the restoration is similar to that of the model tooth for tooth restoration.
Δ: The color tone of the restoration is similar to that of the model tooth for tooth restoration, but the compatibility is not good.
X: The color tone of the restoration does not match the model tooth for tooth restoration.
次に、実施例及び比較例で用いた重合性単量体、重合開始剤等の略号と物質名等を以下に示す。
[重合性単量体]
・UDMA:1,6−ビス(メタクリルエチルオキシカルボニルアミノ)トリメチルヘキサン
・3G:トリエチレングリコールジメタクリレート
・bis−GMA:2,2−ビス[(3−メタクリロイルオキシ−2−ヒドロキシプロピルオキシ)フェニル]プロパン
[重合開始剤]
・CQ:カンファーキノン
・DMBE:N,N−ジメチルp−安息香酸エチル。
[重合禁止剤]
・HQME:ヒドロキノンモノメチルエーテル。
Next, the abbreviations and substance names of the polymerizable monomers, polymerization initiators, etc. used in Examples and Comparative Examples are shown below.
[Polymerizable monomer]
-UDM: 1,6-bis (methacrylicethyloxycarbonylamino) trimethylhexane-3G: triethylene glycol dimethacrylate-bis-GMA: 2,2-bis [(3-methacryloyloxy-2-hydroxypropyloxy) phenyl] Propane [polymerization initiator]
-CQ: camphorquinone-DMBE: N, N-dimethylp-ethyl benzoate.
[Polymerization inhibitor]
-HQME: Hydroquinone monomethyl ether.
表1に示すような重合性単量体を混合し、マトリックスM1、M2を調製した。 The polymerizable monomers shown in Table 1 were mixed to prepare matrices M1 and M2.
[無機球状フィラー]
無機球状フィラーの調製は、特開昭58−110414号公報、特開昭58−156524号公報等に記載の方法で、加水分解可能な有機ケイ素化合物(テトラエチルシリケートなど)と加水分解可能な有機チタン族金属化合物(テトラブチルジルコネートやテトラブチルチタネートなど)とを含んだ混合溶液を、アンモニア水を導入したアンモニア性アルコール(例えば、メタノール、エタノール、イソプロピルアルコール、イソブチルアルコールなど)溶液中に添加し、加水分解を行って反応生成物を析出させる、いわゆるゾルゲル法を用いて調製した。
[Inorganic spherical filler]
The inorganic spherical filler is prepared by a method described in JP-A-58-110414, JP-A-58-156524, etc., to prepare a hydrolyzable organic silicon compound (tetraethyl silicate or the like) and a hydrolyzable organic titanium. A mixed solution containing a group metal compound (tetrabutyl zirconeate, tetrabutyl titanate, etc.) is added to an ammoniacal alcohol (for example, methanol, ethanol, isopropyl alcohol, isobutyl alcohol, etc.) solution introduced with aqueous ammonia. It was prepared using the so-called sol-gel method, in which the reaction product is precipitated by hydrolysis.
[不定形無機フィラー]
不定形シリカ−ジルコニアの調製は、特開平2−132102号公報、特開平3−197311号公報等に記載の方法で、アルコキシシラン化合物を有機溶剤に溶解し、これに水を添加して部分加水分解した後、更に複合化する他の金属のアルコキサイド及びアルカリ金属化合物を添加して加水分解してゲル状物を生成させ、次いで該ゲル状物を乾燥後、必要に応じて粉砕し、焼成して調製した。不定形バリウムガラスは市販のバリウムガラス(ショット社製)を必要に応じて粉砕し、分級して調製した。不定形フッ化イッテルビウムは市販の三フッ化イッテルビウム(トライバッハ社製)を必要に応じて粉砕し、分級して調製した。
実施例及び比較例で用いた無機球状フィラーを表2に、不定形無機フィラーを表3に示す。
[Amorphous inorganic filler]
Atypical silica-zirconia is prepared by dissolving an alkoxysilane compound in an organic solvent by the method described in JP-A-2-132102, JP-A-3-197311, etc., and adding water to the solution to partially hydrolyze the alkoxysilane compound. After decomposition, Alkoxyside and an alkali metal compound of other metals to be further compounded are added and hydrolyzed to form a gel-like substance, and then the gel-like substance is dried, crushed as necessary, and fired. Prepared. The amorphous barium glass was prepared by crushing commercially available barium glass (manufactured by Schott AG) as necessary and classifying it. Amorphous ytterbium fluoride was prepared by pulverizing commercially available ytterbium trifluoride (manufactured by Tribach) as necessary and classifying it.
Table 2 shows the inorganic spherical fillers used in Examples and Comparative Examples, and Table 3 shows the amorphous inorganic fillers.
実施例1〜17
100gの重合性単量体M1又はM2に対して、0.3質量%のCQ、1.0質量%のDMBE、0.15質量%のHQMEを加えて混合し、均一な重合性単量体組成物を調製した。次に、乳鉢に表2および表3に示した各フィラーを計りとり、上記重合性単量体組成物を赤色光下にて徐々に加えていき、暗所にて十分に混練して均一な硬化性ペーストとした。さらにこのペーストを減圧下脱泡して気泡を除去し歯科用硬化性組成物を製造した。得られた歯科用硬化性組成物について、上記の方法に基づいて各物性を評価した。組成及び結果を表4及び表5に示す。表4中の括弧内の数値は、各成分の配合量(単位:質量部)を表す。
Examples 1-17
To 100 g of the polymerizable monomer M1 or M2, 0.3% by mass of CQ, 1.0% by mass of DMBE, and 0.15% by mass of HQME were added and mixed, and a uniform polymerizable monomer was added. The composition was prepared. Next, each of the fillers shown in Tables 2 and 3 is measured in a mortar, the above-mentioned polymerizable monomer composition is gradually added under red light, and the mixture is sufficiently kneaded in a dark place to be uniform. It was a curable paste. Further, this paste was defoamed under reduced pressure to remove air bubbles, and a dental curable composition was produced. The physical characteristics of the obtained dental curable composition were evaluated based on the above method. The composition and results are shown in Tables 4 and 5. The numerical values in parentheses in Table 4 represent the blending amount (unit: parts by mass) of each component.
比較例1〜9
100gの重合性単量体M1に対して、0.3質量%のCQ、1.0質量%のDMBE、0.15質量%のHQMEを加えて混合し、均一な重合性単量体組成物を調製した。次に、乳鉢に表4に示した各フィラーを計りとり、上記重合性単量体組成物を赤色光下にて徐々に加えていき、暗所にて十分に混練して均一な硬化性ペーストとした。さらにこのペーストを減圧下脱泡して気泡を除去し歯科用硬化性組成物を製造した。得られた歯科用硬化性組成物について、上記の方法に基づいて各物性を評価した。組成及び結果を表4及び表5に示す。
Comparative Examples 1-9
To 100 g of the polymerizable monomer M1, 0.3% by mass of CQ, 1.0% by mass of DMBE, and 0.15% by mass of HQME were added and mixed to form a uniform polymerizable monomer composition. Was prepared. Next, each of the fillers shown in Table 4 is measured in a mortar, the above-mentioned polymerizable monomer composition is gradually added under red light, and the paste is sufficiently kneaded in a dark place to provide a uniform curable paste. And said. Further, this paste was defoamed under reduced pressure to remove air bubbles, and a dental curable composition was produced. The physical characteristics of the obtained dental curable composition were evaluated based on the above method. The composition and results are shown in Tables 4 and 5.
比較例10
100gの重合性単量体M2に対して、0.3質量%のCQ、1.0質量%のDMBE、0.15質量%のHQMEを加えて混合し、均一な重合性単量体組成物を調製した。次に、乳鉢に表4に示した無機球状フィラーを計りとり、上記重合性単量体組成物を赤色光下にて徐々に加えていき、さらに二酸化チタン(白顔料)を0.070g、ピグメントイエロー(黄顔料)を0.002g、ピグメントレッド(赤顔料)を0.0006g、ピグメントブルー(青顔料)を0.0002g加えて暗所にて十分に混練して均一な硬化性ペーストとした。さらにこのペーストを減圧下脱泡して気泡を除去し歯科用複合修復材料を製造した。目視評価で高色度模型歯のA系統に適合する色調(A4相当)であった。続いて、上記の方法に基づいて各物性を評価した。組成及び結果を表4及び表5に示す。
Comparative Example 10
To 100 g of the polymerizable monomer M2, 0.3% by mass of CQ, 1.0% by mass of DMBE, and 0.15% by mass of HQME were added and mixed to form a uniform polymerizable monomer composition. Was prepared. Next, the inorganic spherical filler shown in Table 4 was weighed into a dairy pot, the above polymerizable monomer composition was gradually added under red light, and 0.070 g of titanium dioxide (white pigment) was added to the pigment. 0.002 g of yellow (yellow pigment), 0.0006 g of pigment red (red pigment), and 0.0002 g of pigment blue (blue pigment) were added and sufficiently kneaded in a dark place to obtain a uniform curable paste. Further, this paste was defoamed under reduced pressure to remove air bubbles, and a dental composite restoration material was produced. By visual evaluation, the color tone (equivalent to A4) was suitable for the A system of the high chromaticity model tooth. Subsequently, each physical property was evaluated based on the above method. The composition and results are shown in Tables 4 and 5.
実施例1〜17の結果から理解されるように、本発明で規定する条件を満たしていると、歯科用硬化性組成物は黒背景下で光の干渉による黄〜赤色の着色光を示し、色調適合性が良好であり、高い曲げ強さを示すことが分かる。 As can be seen from the results of Examples 1-17, when the conditions specified in the present invention are met, the dental curable composition exhibits a yellow to red colored light due to light interference under a black background. It can be seen that the color tone compatibility is good and the bending strength is high.
比較例1〜2の結果から理解されるように、平均粒子径が230nm又は280nmの無機球状フィラーのみをフィラーとして配合した場合、黒背景下での光の干渉による黄色および赤色の着色光は明瞭に確認されるが、硬化体のコントラスト比が低いため、IV級窩洞に対しては良好な色調適合性が得られない。 As can be understood from the results of Comparative Examples 1 and 2, when only the inorganic spherical filler having an average particle diameter of 230 nm or 280 nm is blended as the filler, the yellow and red colored lights due to the interference of light under the black background are clear. However, due to the low contrast ratio of the cured product, good color compatibility cannot be obtained for class IV cavities.
比較例3の結果から理解されるように、平均粒子径が178nmの無機球状フィラーのみをフィラーとして配合した場合、黒背景下での光の干渉による着色光は青色であり、且つ硬化体のコントラスト比が低いため、IV級窩洞に対しては良好な色調適合性が得られない。 As can be understood from the results of Comparative Example 3, when only an inorganic spherical filler having an average particle diameter of 178 nm is blended as a filler, the colored light due to light interference under a black background is blue and the contrast of the cured product is high. Due to the low ratio, good color compatibility is not obtained for class IV cavities.
比較例4〜8の結果に示されるように、球状フィラーを用いずに不定形フィラーを用いた場合には、歯科用硬化性組成物は黒背景下で着色光を示さず、また、比較例9の結果に示されるように、不定形無機フィラーの平均粒子径が1000nmを超え3000nm未満の範囲を満たしておらず、かつ不定形無機フィラーの屈折率と重合性単量体成分を重合して得られる重合体との屈折率との差が大きい場合には、色調適合性に劣っている。 As shown in the results of Comparative Examples 4 to 8, when the amorphous filler was used instead of the spherical filler, the dental curable composition did not show colored light under a black background, and Comparative Examples As shown in the result of 9, the average particle size of the amorphous inorganic filler does not satisfy the range of more than 1000 nm and less than 3000 nm, and the refractive index of the amorphous inorganic filler and the polymerizable monomer component are polymerized. When the difference from the refractive index with the obtained polymer is large, the color tone compatibility is inferior.
比較例10の結果から理解されるように、顔料を添加して色調を調整(高色度模型歯のA系統に適合する色調(A4相当))した歯科用硬化性組成物は、色差計((有)東京電色製、「TC−1800MKII」)を用いて、背景色黒、背景色白で分光反射率を測定したところ、背景色黒、背景色白ともに添加した顔料に応じた分光反射特性を示すことが観察された。高色度模型歯のA系統に適合する色調(A4相当)への色調適合性は比較的良好であったが、他の模型歯への色調適合性は低いものであった。 As can be understood from the results of Comparative Example 10, the dental curable composition in which the color tone was adjusted by adding a pigment (color tone suitable for the A system of the high-chromaticity model tooth (equivalent to A4)) was a color difference meter (a color difference meter (equivalent to A4)). When the spectral reflectance was measured with a black background color and a white background color using "TC-1800MKII" manufactured by Tokyo Denshoku Co., Ltd., the spectral reflectance characteristics according to the pigment added to both the black background color and the white background color were obtained. It was observed to show. The color tone compatibility of the high-chromaticity model tooth with the color tone (equivalent to A4) suitable for the A system was relatively good, but the color tone compatibility with other model teeth was low.
Claims (7)
前記重合性単量体成分(A)を重合して得られる重合体の25℃における屈折率をnPとし、前記無機球状フィラー(B)の25℃における屈折率をnFBとし、前記不定形無機フィラー(C)の25℃における屈折率をnFCとしたときに、
nFB>nP であり、且つ 0.000≦nFC−nP≦0.002 である、
ことを特徴とする歯科用硬化性組成物。 The polymerizable monomer component (A) has an average primary particle size in the range of 100 nm or more and 1000 nm or less, and 90% or more of the total number of particles in the number-based particle size distribution is in the range of 5% before and after the average primary particle size. A dental curable composition comprising an inorganic spherical filler (B) present in, an amorphous inorganic filler (C) in the range of more than 1000 nm and less than 3000 nm, and a polymerization initiator (D).
The refractive index of the polymer obtained by polymerizing the polymerizable monomer component (A) at 25 ° C. is n P, and the refractive index of the inorganic spherical filler (B) at 25 ° C. is n FB. refractive index at 25 ° C. of the inorganic filler (C) a when a n FC,
n FB > n P and 0.000 ≦ n FC −n P ≦ 0.002.
A dental curable composition characterized by that.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019213309A JP7422994B2 (en) | 2019-11-26 | 2019-11-26 | Dental curable composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019213309A JP7422994B2 (en) | 2019-11-26 | 2019-11-26 | Dental curable composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021084865A true JP2021084865A (en) | 2021-06-03 |
JP7422994B2 JP7422994B2 (en) | 2024-01-29 |
Family
ID=76086826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019213309A Active JP7422994B2 (en) | 2019-11-26 | 2019-11-26 | Dental curable composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7422994B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023191112A1 (en) * | 2022-04-01 | 2023-10-05 | クラレノリタケデンタル株式会社 | Dental curable composition having favorable color compatibility |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6011505A (en) * | 1983-06-30 | 1985-01-21 | Tokuyama Soda Co Ltd | Polymerizable composite composition |
JP2010215694A (en) * | 2009-03-13 | 2010-09-30 | Tokuyama Dental Corp | Curable composition for adjusting color tone of opaque paste |
WO2011158742A1 (en) * | 2010-06-18 | 2011-12-22 | 株式会社トクヤマデンタル | Dental restorative composite |
JP2012153640A (en) * | 2011-01-26 | 2012-08-16 | Tokuyama Dental Corp | Complex restorative material for dental use |
WO2012176877A1 (en) * | 2011-06-24 | 2012-12-27 | 株式会社トクヤマデンタル | Dental restorative material |
WO2014148293A1 (en) * | 2013-03-19 | 2014-09-25 | 株式会社トクヤマデンタル | Dental filling and restorative material kit |
WO2015125470A1 (en) * | 2014-02-20 | 2015-08-27 | クラレノリタケデンタル株式会社 | Dental restorative composition |
WO2015141683A1 (en) * | 2014-03-19 | 2015-09-24 | 株式会社トクヤマデンタル | Orthodontic adhesive and orthodontic adhesive kit |
JP6250245B2 (en) * | 2015-10-21 | 2017-12-20 | 株式会社トクヤマデンタル | Curable composition and dental filling restorative material |
-
2019
- 2019-11-26 JP JP2019213309A patent/JP7422994B2/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6011505A (en) * | 1983-06-30 | 1985-01-21 | Tokuyama Soda Co Ltd | Polymerizable composite composition |
JP2010215694A (en) * | 2009-03-13 | 2010-09-30 | Tokuyama Dental Corp | Curable composition for adjusting color tone of opaque paste |
WO2011158742A1 (en) * | 2010-06-18 | 2011-12-22 | 株式会社トクヤマデンタル | Dental restorative composite |
JP2012153640A (en) * | 2011-01-26 | 2012-08-16 | Tokuyama Dental Corp | Complex restorative material for dental use |
WO2012176877A1 (en) * | 2011-06-24 | 2012-12-27 | 株式会社トクヤマデンタル | Dental restorative material |
WO2014148293A1 (en) * | 2013-03-19 | 2014-09-25 | 株式会社トクヤマデンタル | Dental filling and restorative material kit |
WO2015125470A1 (en) * | 2014-02-20 | 2015-08-27 | クラレノリタケデンタル株式会社 | Dental restorative composition |
WO2015141683A1 (en) * | 2014-03-19 | 2015-09-24 | 株式会社トクヤマデンタル | Orthodontic adhesive and orthodontic adhesive kit |
JP6250245B2 (en) * | 2015-10-21 | 2017-12-20 | 株式会社トクヤマデンタル | Curable composition and dental filling restorative material |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023191112A1 (en) * | 2022-04-01 | 2023-10-05 | クラレノリタケデンタル株式会社 | Dental curable composition having favorable color compatibility |
Also Published As
Publication number | Publication date |
---|---|
JP7422994B2 (en) | 2024-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2016340522B2 (en) | Curable composition and dental filling restorative material | |
JP6762623B2 (en) | Dental curable composition | |
JP7114090B2 (en) | Curable composition | |
JP5762405B2 (en) | Dental composite restoration material | |
US11058608B2 (en) | Curable composition for dental use, and method for producing same | |
JP7099721B2 (en) | Photocurable compositions and dental restoration filling materials | |
KR102698521B1 (en) | Resin block for dental cutting processing | |
JP7075635B2 (en) | Dental curable composition | |
JP6732257B2 (en) | Composite material | |
JP7422994B2 (en) | Dental curable composition | |
JP6945818B2 (en) | Curable composition | |
JP7422996B2 (en) | Dental curable composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220705 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230829 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230925 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240109 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240109 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7422994 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |